Career Objective:

Professional Experience:

• November 2013 – present: Principal and Tunnell Government Services IRF-Frederick Team Lead, Tunnell Government Services, Inc., Bethesda, Maryland, USA; and Virology Lead, NIH/NIAID/DCR Integrated Research Facility at Fort Detrick (IRF-Frederick), National Interagency Biodefense Campus (NIBC), Fort Detrick, Frederick, Maryland, USA.
• March 2008 – November 2013: Managing Consultant, Tunnell Government Services, Inc., Bethesda, Maryland, USA; and Lead Virologist, NIH/NIAID/DCR Integrated Research Facility at Fort Detrick (IRF-Frederick), National Interagency Biodefense Campus (NIBC), Fort Detrick, Frederick, Maryland, USA.
• May – November 2007: Subcontractor. Battelle Memorial Institute, Columbus, Ohio, USA.
• January 2005 – March 2008: Research Scholar. Division of Tumor Virology, New England Primate Research Center, Department of Microbiology and Molecular Genetics, Harvard Medical School, Southborough, Massachusetts, USA. Advisor: Associate Prof. Michael R. Farzan, PhD.
• October 2003 – December 2004: Research Fellow. Partners AIDS Research Center, Channing Laboratory, Brigham & Women’s Hospital, Harvard Medical School, Cambridge, Massachusetts, USA. Advisor: Assistant Prof. Michael R. Farzan, PhD.
• June – October 2001: Technical Diplomat (US Department of State sponsorship) and Senior Project Manager for the International Science and Technology Center (ISTC), Moscow, Russia, representing the US Department of Defense’s [Defense Threat Reduction Agency] (DTRA), Alexandria, Virginia, USA. Stationed at Государственный научный центр вирусологии и биотехнологии «Вектор» [State Research Center for Virology and Biotechnology “Vector”], Koltsovo, Novosibirsk Region, Siberia, Russia. This project included two two-week briefings in Washington, DC, USA in April 2001, and in Moscow, Russia in June 2001, respectively; and two debriefings of one week each in the same cities in October 2001. Advisors: Barbara Johnson, PhD, RBP; James C. Bartholomew, PhD.
• April 2001 – September 2003: Subcontractor. Science Applications International Corporation – Threat Reduction Support Center (SAIC-TRSC), Alexandria, Virginia, USA. Advisors: Barbara Johnson, PhD, RBP; James C. Bartholomew, PhD.
• April 1998 – April 1999: Graduate research assistant. Hood College, Frederick, Maryland, USA. Advisor: Kevin Anderson, PhD.

Teaching Experience:

• February 2004 – March 2008: Laboratory supervisor of a Harvard College undergraduate student (February 2004 – April 2005), three Harvard graduate students (August – December 2004; January 2005 – December 2007; July – September 2007), and an Utrecht University undergraduate student (October 2006 – April 2007), New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts, USA (2005 – 2008); and Partners AIDS Research Center, Brigham and Women’s Hospital, Harvard Medical School, Cambridge, Massachusetts, USA (2004).
• April 1996 – April 1997: Graduate teaching assistant (tutor for biochemistry students of both graduate and undergraduate levels). Projekttutorium [Tutorial]. Freie Universität Berlin, Fachbereich Chemie [Department of chemistry], Berlin, Germany. Advisor: Prof. Dr. rer. nat. Ferdinand Hucho.

Education:

• November 2004: Medizinische Approbation [German Medical License].
• November 2003 – December 2008: Cand. rer. nat. [PhD student], Fachbereich Biologie, Chemie, Pharmazie [Department of biology, chemistry, pharmacy], Freie Universität Berlin, Berlin, Germany; New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts, USA (2005-2008); and Partners AIDS Research Center, Brigham and Women’s Hospital, Harvard Medical School, Cambridge, Massachusetts, USA (2003-2004). Subject: Filoviruses Attach to a Common Cell-Surface Molecule via Distinct and Strongly Immunogenic Receptor-binding Regions, and Modulate Cell Entry Through Δ-Peptides. Advisors: Prof. Dr. rer. nat. Volker Haucke (Germany), Associate Prof. Michael R. Farzan, PhD (USA). Submitted to the dissertation committee on September 4, 2008; defended summa cum laude on November 12, 2008; degree received on December 12/2008.
• October 2000 – September 2004: Medizinische Doktorarbeit [MD dissertation]. Charité – Universitätsmedizin Berlin [Charité – University Medicine], Campus Benjamin Franklin, Institut für Infektionsmedizin [Institute of Medicine of Infection], Berlin, Germany. Subject: Experiences of the First Western Scientist With Permission to Work Inside A Former Soviet Biowarfare Facility. Advisor: Prof. Dr. med. Helmut Hahn. 125 pages. Submitted to the dissertation committee on December 15, 2003; defended cum laude on June 15, 2004; degree received on September 3, 2004.
• June 2000 – April 2003: Cand. rer. medic. [PhD student in medical sciences], Fachbereich Humanmedizin [Department of medicine], Freie Universität Berlin, Berlin, Germany. Medizinwissenschaftliche Doktorarbeit [PhD dissertation in medical sciences]. Subject: Mononegavirales: Filoviridae – The Marburg- and Ebola-like Viruses. A Bibliographic Review of the Scientific World Literature. Advisors: Prof. Dr. med. Helmut Hahn and Prof. Dr med. Detlev H. Krüger. 656 pages; 3,100 references. Submitted to the dissertation committee on July 8, 2002; defended magna cum laude on March 11, 2003; degree received on April 11, 2003.
• October 1995 – November 2002: Cand. med. [Medical student], Fachbereich Humanmedizin [Department of medicine], Freie Universität Berlin, Berlin, Germany. November 2002: Arzt [Physician].
• October 1993 – April 1999: Biochemie-Student [MS student in biochemistry], Fachbereich Biologie, Chemie, Pharmazie [Department of biology, chemistry, pharmacy], Freie Universität Berlin, Berlin, Germany; Department of Molecular Virology, Virology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick. Maryland, USA. April 1998-April 1999: Diplomarbeit [MS thesis] in Biochemistry. Subject: Evaluation of expression and encapsidation properties of recombinant Poliovirus RNA replicons expressing Ebola virus glycoproteins. Advisors: Prof. Dr. med. Werner Reutter (Germany), and Kevin Anderson, PhD (USA). Biochemie-Diplom [Master of Biochemical Sciences/MS degree] received in April 1999 (grade: ausgezeichnet [with distinction]).
• July 1992: Zeugnis der Allgemeinen Hochschulreife/Abitur [Graduation from the German Gymnasium], Dietrich-Bonhoeffer-Gymnasium Oberasbach, Bavaria, Germany.

Clerkships, Electives, Field Trips, and Rotations:

• June – October 2002: Final year clinical elective. Department of Internal Medicine, G. F. Jooste Hospital, The University of Cape Town, Manenberg, South Africa. Advisor: Prof. Blythe, MD.
• February – June 2002: Final year clinical elective. Dipartimento di Scienze Chirurgiche, Ortopediche, Traumatologiche ed Emergenze [Department of surgical sciences, orthopedics, trauma, and emergencies], Facoltà di Medicina e Chirurgia [Medical and surgical faculty], Azienda Universitaria Policlinico [University hospital campus], Università Degli Studi di Napoli “Federico II” [University of Naples “Federico II”], Naples, Italy. Advisors: Prof. Raffaele Jovino, MD, PhD, and Mario Musella, MD.
• November 2001 – February 2002: Final year clinical elective. Dipartiment ta’ Maternita [Department of obstetrics and gynecology], Sptar San Luqa [St. Luke’s hospital], L-Università ta’ Malta [University of Malta], Gwardamanġa, Malta. Advisor: Francis Bonello, MD.
• April – October 2001: Laboratory rotation. First Western scientist with permission to work in a laboratory of a former Soviet bioweapons facility: Государственный научный центр вирусологии и биотехнологии «Вектор» [State Research Center for Virology and Biotechnology “Vector”], Koltsovo, Novosibirsk Region, Siberia, Russia. Project: Study of the Genomic Structure of Crimean-Congo Hemorrhagic Fever Virus Isolates Circulating in the Southern Region of NIS Countries (International Science and Technology Center Project No. 1291-2). Advisors: Владимир Семенович Петров [Vladimir Semyonovich Petrov], PhD (Russia), Barbara Johnson, PhD (SAIC, USA).
• November – December 2000: Famulatur [Medical clerkship]. 감염내과 [Department of Infectious Diseases], 길병원 [Gil Medical Center], 가천의과대학교 [Gachon Medical School], Inchon, South Korea. Project: Participation in the clinical assessment of patients with exotic infectious diseases (hemorrhagic fever with renal syndrome, leptospirosis, tsutsugamushi disease). Advisors: Prof. Dr. med. Dr. rer. nat. Walter C. Schüller, and Prof. 조용균 [Cho Yong-Kyun], MD.
• October 1999 – January 2000: Famulatur [Laboratory rotation] at the Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. Participation in projects concerning the stabilization of the quaternary structure of various HIV-1 glycoprotein trimers as a means to create novel vaccine candidates. Advisors: Prof. Joseph G. Sodroski, MD, and Xinzhen Yang, MD, PhD.
• August – October 1999: Famulatur [Medical clerkship] at the Emerging Infectious Diseases Pathology Activity, Division of Viral and Rickettsial Diseases, National Centers for Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA. Advisor: Assistant Prof. Sherif R. Zaki, MD, PhD.
• August 1997: Freie Mitarbeit [Laboratory rotation]. Institut für Organische Chemie [Institute of organic chemistry], Freie Universität Berlin, Berlin, Germany. Participation in projects concerning the 1H-, 13C-NMR, and mass spectroscopy of novel organic polymers. Advisor: Prof. Dr. rer. nat. A.-D. Schlüter.
• July 1997: Field trips to study sites at Fort Lewis (La Plata County, Southwest Colorado) and Molina (Mesa County, West Central Colorado), USA. Trapping of various rodents and examination of these rodents for infections with members of the genus Hantavirus under field biosafety level 3 (BSL-3) conditions. Goal: definition of Sin nombre virus epidemiology/epizoology. Advisor: Prof. Charles H. Calisher, PhD (Colorado State University, Fort Collins, Colorado, USA).
• May – July 1997: Freie Mitarbeit [Laboratory rotation] at the Arthropod-Borne and Infectious Diseases Laboratory, Colorado State University, Fort Collins, Colorado, USA. Participation in projects concerning the establishment of an infectious cDNA clone of LaCrosse virus and the characterization of RNA genome segment reassortment between LaCrosse virus and the related Snowshoe hare virus. Advisors: Prof. Barry Beaty, PhD, and Monica Borucki.
• February – May 1997: Pflegepraktikum [Volunteer in patient care] in the Emergency Center, Overlake Hospital Medical Center, Bellevue, Washington, USA. Volunteer coordinator: Mari-Pat Corrigan.
• July – October 1996: Freie Mitarbeit [Laboratory rotation] in the Division of Human Retrovirology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. Participation in projects concerning the definition of the quaternary structure of the transmembrane protein gp41 of HIV-1. Department chief: Prof. Joseph G. Sodroski, MD. Immediate advisors: Hye-Ryun Choe, PhD, and Michael R. Farzan.
• Summer of 1996: Praktikum [Course] at the Max-Planck-Institut für Molekulargenetik [Max Planck institute for molecular genetics], Berlin, Germany. Project: Characterization of tRNA-binding processes at the prokaryotic ribosome. Advisor: Prof. Dr. rer. nat. Knud H. Nierhaus.
• July 1992 – October 1993: Zivildienst [Social community service] at the Institut für Klinikhygiene, medizinische Mikrobiologie und klinische Infektiologie am Städtischen Krankenhaus Nürnberg Nord [Department of clinical hygiene, medical microbiology, and clinical infectiology at the northern city hospital of Nuremberg], Nuremberg, Bavaria, Germany. Projects: isolation and identification of clinical relevant bacteria, fungi and parasites; creation and supervision of type culture collections; processing of patient specimens; sterility tests of both clinical instruments and certain food products; minimum inhibitory concentration (MIC) determination experiments for the definition of the efficacy of the new antibiotic Meropenem; Mitbeteiligung am bakteriologischen Ringversuch [Participation in national quality control tests]. Department chief: Priv.-Doz. Dr. med. Heinz-Michael Just. Immediate advisor: Dr. med. Daniela Lehnhardt.

Professional Recognition and Honors:

• ad hoc reviewer for Antiviral Research (Elsevier/North Holland Press, Amsterdam, The Netherlands), Applied Biosafety—Journal of the American Biological Safety Association (Mundelein, Illinois, USA), Archives of Virology (Springer, Vienna, Austria), Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science (Mary Ann Liebert, New Rochelle, New York, USA), Biotechnology Progress (American Institute of Chemical Engineers, New York, New York, USA), BMC Veterinary Research (London), British Microbiology Research Journal (Sciencedomain International, Gurgayon, Haryana, India), Database—The Journal of Biological Databases and Curation (Oxford University Press, Oxford, UK), DNA and Cell Biology (Mary Ann Liebert, New Rochelle, New York, USA), Frontiers in Public Health (Lausanne), Future Virology (Future Medicine, London, UK), International Journal of Microbiology (Hindawi, Nasr City, Egypt), Intervirology (Karger, Basel, Switzerland), JAMA—Journal of the American Medical Association (American Medical Association, Chicago, Illinois, USA), Journal of Applied Microbiology (Blackwell Publishing, Hoboken, New Jersey, USA), Journal of Forensic Sciences (Blackwell Publishing, Chicago, Illinois, USA), Journal of General Virology (Society for General Virology, London, UK), Journal of Virology (ASM, Washington, DC, USA), Healthcare (Molecular Diversity Preservation International, Basel, Switzerland), Immunotherapy (Future Medicine, London, UK), Nature Protocols (Macmillan Press, London, UK), Open Forum Infectious Diseases (Oxford University Press, Oxford, UK), PeerJ (Corte Madera), PLoS Neglected Tropical Diseases (Public Library of Science, San Francisco, California, USA), PLoS ONE (Public Library of Science, San Francisco, California, USA), PLoS Pathogens (Public Library of Science, San Francisco, California, USA), Science (Washington, DC), The Lancet. Infectious Diseases (New York), The Veterinary Journal (Elsevier Press, New York, New York, USA), Viral Immunology (Mary Ann Liebert, New York, New York, USA), Virologica Sinica (Springer, Vienna, Austria), Virology (Elsevier Press, New York, New York, USA), Virology Journal (BioMed Central, London, UK), Viruses (Molecular Diversity Preservation International, Basel, Switzerland), Wellcome Trust (London, UK), and Zoonoses and Public Health (Berlin).
• 01/01/2015-12/31/2017: Member, Editor Board, Journal of Virology (ASM Press, Washington, DC, USA).
• 12/05/2014-present: Co-organizer, International Conference “viruses 2016 - At the Forefront of Virus–Host Interactions”, January 26-28, 2016, Pharmacenter, Basel, Switzerland.
• 12/04/2014-present: Editor, SpringerPlus (Springer, Springer, Vienna, Austria).
• 09/23/2014-present: Member, International Committee on Taxonomy of Viruses (ICTV) Bunyaviridae Study Group.
• 09/10/2014-present: Member, International Committee on Taxonomy of Viruses (ICTV) Bornaviridae Study Group.
• 09/08/2014-present: Member, International Committee on Taxonomy of Viruses (ICTV) Arenaviridae Study Group.
• 08/31/2014-present: Member, International Committee on Taxonomy of Viruses (ICTV) Nyamiviridae Study Group.
• 07/29/2014-present: Member, International Committee on Taxonomy of Viruses (ICTV) Bacterial and Archaeal Viruses Subcommittee.
• 07/29/2014-present: Member, International Committee on Taxonomy of Viruses (ICTV) Animal dsRNA- and ssRNA-Viruses Subcommittee.
• 07/29/2014-present: Member, Executive Committee of the International Committee on Taxonomy of Viruses (ICTV).
• 06/03/2014-present: Associate Editor (RNA Virology Section), PLoS [Public Library of Science] Pathogens (Public Library of Science, San Francisco, California, USA).
• 04/05/2014-06/03/2014: Guest Editor, PLoS [Public Library of Science] Pathogens (Public Library of Science, San Francisco, California, USA).
• 01/01/2014-present: Special Issue Editor, Viruses – Advances in Filovirus Research 2014 (MDPI, Basel, Switzerland).
• 12/04-06/2013: Subject Matter Expert (SME), US Department of State bioengagement mission to Turkey.
• 07/19/2013-present: Editor, Viruses (MDPI, Basel, Switzerland).
• 05/28/2013-present: Editor, BioMed Research International (Hindawi, New York, New York, USA).
• 03/05/2013-present: Member, NCBI Genome Annotation – Virus Working Group, Bethesda, Maryland, USA.
• 02/27/2013-present: Editor, OA Virology (Open Access Publishing London, London, UK).
• 02/25/2013-present: Editor, Вопросы вирусологии [Voprosy virusologii - Problems of Virology (Medicina, Moscow, Russia).
• 02/12/2013-present: Viral RefSeq Genome Advisor, order Mononegavirales, NCBI [National Center for Biotechnology Information] Reference Sequence Database (RefSeq), Bethesda, Maryland, USA.
• 01/24/2013-present: Editor, World Journal of Virology (Baishideng Publishing, Hong Kong, China).
• 01/01/2013-present: Editor, Virologica Sinica (Springer, Vienna, Austria).
• 09/28/2012-present: Editor, PLoS [Public Library of Science] ONE (Public Library of Science, San Francisco, California, USA).
• 07/31/2012-present: Editor, Journal of Bioterrorism & Biodefense (Los Angeles, California, USA).
• 05-06/06/2012: Session Moderator and Poster Judge, FDA 1st Medical Countermeasures Regulatory Science Symposium, June 5-6, FDA Headquarters, Silver Spring, Maryland, USA.
• 04/20/2012-present: Chair, International Committee on Taxonomy of Viruses (ICTV) Mononegavirales Study Group.
• 03/22/2012-08/28/2012: Editor, Conference Papers in Microbiology (New York, New York, USA).
• 01/01/2012-12/31/2012: Special Issue Editor, Viruses – Advances in Filovirus Research 2012 (MDPI, Basel, Switzerland).
• 10/20/2011-present: Chair, International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group.
• 09/12/2011-present: Officer of the International Union of Microbiological Societies (IUMS) responsible for Virology Division News (VDN); VDN Special Editor, Archives of Virology (Springer, Vienna, Austria).
• 08/25/2011: Tunnell Consulting, Inc., Shining Star Award.
• 2011-present: Observer and Subject Matter Expert, DoD/DHHS Filovirus Animal Non-Clinical Group (FANG).
• 2011-2012: Special Issue Editor, Viruses (Basel, Switzerland), Special issue “Advances in Filovirus Research”
• 05/30/2011-06/01/2011: Participant, first planning workshop for the project “Developing a Framework for an International Faculty Development Project on Education about Research in the Life sciences with Dual Use Potential” by the National Research Council of the US National Academy of Sciences, Trieste, Italy.
• 03/17/2010: Tunnell Consulting, Inc., Shining Star Award.
• 2010: Subject Matter Expert (SME), US Department of Homeland Security Bioterrorism Risk Assessment (DHS BTRA): Filoviruses.
• 2010: Member, Reviewer Team for the Center for International and Security Studies at Maryland (CISSM) Experiments of Concern Portal (other members: Alan Pearson, Jonas Siegel, Kathryn Nixdorf, Richard Ebright).
• 01/13/2010-09/14/2011: Member, International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group (other members: Stephan Becker, Hideki Ebihara, Thomas Geisbert, Peter B. Jahrling, Yoshihiro Kawaoka, Thomas Ksiazek, Sergey Netesov, Stuart Nichol, Clarence J. Peters, and Viktor Volchkov).
• 2009-2011: Member, ad hoc committee on “Animal Models for Assessing Countermeasures to Bioterrorism Agents”, Institute for Laboratory Animal Research (ILAR), Division on Earth and Life Studies, The National Academies of Sciences, Washington, DC, USA (other members: George W. Korch, Jr. (chair), Steven M. Niemi, Nicholas H. Bergman, Daniel J. Carucci, Susan A. Ehrlich, Gigi Kwik Gronvall, Thomas Hartung, Elizabeth Heitman, Malak Kotb, C. Rick Lyons, Stephen S. Morse, Frederick A. Murphy, Vikram S. Patel, and James R. Swearengen).
• 2007-2008: Principal Investigator, New England Regional Center for Excellence/Biodefense and Emerging Diseases (NERCE/BEID) Career Development Fellowship “IDENTIFICATION OF CELL-SURFACE RECEPTORS OF NIAID PRIORITY PATHOGENS”.
• 2006-10/31/2009: Member of the Center for Arms Control and Nonproliferation’s CBW Scientist Working Group, Washington, DC, USA (other members: Marie Chevrier, David Fidler, Martin Furmanski, John Gilbert, Elisa D. Harris, Lynn Klotz, Gregory Koblentz, Milton Leitenberg, James Leonard, Jack Melling, Alan Pearson, Barbara Hatch Rosenberg, Kathleen M. Vogel, Mark Wheelis, and Jack Woodall).
• 2006: Nominator for the MacArthur Fellow Program, The John D. and Catherine T. MacArthur Foundation, Chicago, Illinois, USA.
• 2005-2007: Principal Investigator, New England Regional Center for Excellence/Biodefense and Emerging Diseases (NERCE/BEID) Career Development Fellowship “IDENTIFICATION OF CELL-SURFACE RECEPTORS OF NIAID PRIORITY PATHOGENS”.
• 2004-2008: Regular invitee to the monthly “MIT Faculty Dinner Series on Biosecurity,” Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
• 2004-present: Member of the Editorial Board, Applied Biosafety – Journal of the American Biological Safety Association (Mundelein, Illinois, USA).
• 2002: Member of the scientific committee of the symposium “Facing the Threat by Intentionally Spread Microorganisms”, November 30 – December 1, Institut für Infektionsmedizin [Institute of Medicine of Infection], Universitätsklinikum Benjamin Franklin [Benjamin Franklin Medical Center], Freie Universität Berlin, Germany.
• 2000: Invitation to attend the UNESCO Lecture “The Jerusalem Declaration on Science for Peace. A UNESCO Initiative to Prevent the Abuse of Biological Knowledge. The Jerusalem Statement on the Need to Eliminate Weapons of Mass Destruction and to Prevent the Misuse of Biological and Chemical Sciences”, given by Prof. Dr. Yechiel Becker (The Hebrew University of Jerusalem, Israel) on June 27 at the Department of Medicine, Freie Universität Berlin, Berlin, Germany.
• 1999: Representative of the Department of Medicine, Freie Universität Berlin, Germany, at the 49th Meeting of Nobel Laureates, June 28 – July 2, Lindau, Germany.

Clearances:

• 06/23/2011-present: US Access National Agency Check and Inquiries (ANACI) Clearance
• 06/30/2008-present: Approval for Access to Select Agent(s) and/or Toxins (US Department of Justice ID: C-JK-030319)

Special Training:

• 1999: Attendant of the 1999 Satellite Broadcast: “Biological Warfare and Terrorism – The Military and Public Health Response”, September 21-23. Organized by the Food and Drug Administration, the Centers for Disease Control and Prevention, and the United States Research Institute of Infectious Diseases. Passing of the concomitant exam.
• 1998: Laboratory Safety Operations Training (Biosafety Levels 3 and 4) at the United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, USA.
• 1998: ILC Dover Chemturion Encapsulation Suit Training for Protection in Biosafety Level 4 Environments at the United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, USA.
• 1998: RACAL Respiratory Protection Course at the United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, USA.
• 1998: Investigator Training Seminar: “Laboratory Animal Care and Use” at the United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, USA.
• 1997: Insectary training at the Arthropod-Borne and Infectious Diseases Laboratory, Colorado State University, Fort Collins, Colorado, USA.
• 1996: Laboratory Safety Operations Training (Biosafety Level 3) at the Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.

Briefings:

• 04/06/2011: Filovirus Prototype Establishment for Biodefense R&D Standardization. Briefing to the US Department of Defense (DoD) Defense Threat Reduction Agency (DTRA), Alexandria, Virginia, USA (90 min).
• 02/15/2011: Virus Prototype Establishment for Biodefense R&D Standardization. Briefing to the The Tauri Group, Alexandria, Virginia, USA (90 min).
• 11/15/2009: Filovirus Animal Models. Closed briefing for the National Academy of Sciences Workshop “Animal Models for Assessing Countermeasures to Bioterrorism Agents,” Washington, DC, USA (60 min).
• 06/21/2007: The transformation of the former Soviet biological-weapons research facility SRCVB “Vector”. Battelle briefing to government client, Baltimore area, MD, USA (120 min).
• 06/21/2007: Ebolaviruses and marburgviruses – Public health threat and BW threat assessment. Battelle briefing to government client, Baltimore area, MD, USA (120 min).
• 06/21/2007: Introduction to viral hemorrhagic fever agents. Battelle briefing to government client, Baltimore area, MD, USA (60 min).

Guest Lectures/Seminars:

• 12/19/2014: Ebola virus and other filoviruses – myths, facts, and threats. Christmas Lecture 2014 of the Austrian Chapter of the American Society for Microbiology (ASM), Austrian Agency for Health and Food Safety (AGES), Vienna, Austria (60 min.).
• 12/01/2014: The explosion of viral genomics data: A need for consistent annotation and nomenclature synthesizing ICTV and NCBI requirements. Presented at the NICBR [National Interagency Confederation for Biological Research] Symposium “The expanding role of deep sequencing on biological research: A plethora of 'omics' words”, December 1, Fort Detrick, Frederick, Maryland, USA (20 min.).
• 10/29/2014: Overview of the diversity, cross-species transmission, and pathologic potential of taxonomically distinct simian arteriviruses. Presented at 中国科学院第六届新生病毒性疾病控制学术研讨会 [Zhōngguó kēxuéyuàn dì liù jiè xīnshēng bìngdú xìng jíbìng kòngzhì xuéshù yántǎo huì/The 6th Symposium on Emerging Viral Diseases], October 29-31, Wǔhàn, Húběi Province, China (20 min.)
• 07/29/2014: Progress and challenges in filovirus taxonomy. Presented at the XVIth International Congress of Virology, July 27 – August 1, Montréal, Québec, Canada (15 min).
• 07/22/2014: Barriers to Bioweapons – The Case of Filoviruses. Lecture presented as part of the Summer Professional Course IS 0300 “Pandemics, Bioterrorism, and International Security”, July 21-23, George Mason University, Arlington, Virginia, USA (120 min).
• 08/23/2013: Filovirus Epidemiological/Clinical Research and Numbers – Real or Misinterpreted? Presented at the Filovirus Medical Countermeasures (MCM) Workshop, August 22-23, Fishers Lane Conference Center, Rockville, Maryland, USA (40 min).
• 07/22/2013: Barriers to Bioweapons – The Case of Filoviruses. Lecture presented as part of the Summer Professional Course HSEC 0300 F02 “Pandemics, Bioterrorism, and International Security”, July 22-24, George Mason University, Fairfax, Virginia, USA (120 min).
• 10/29/2012: The US NIH/NIAID Integrated Research Facility at Fort Detrick (IRF-Frederick) – Capabilities and Opportunities for Collaboration. Presented at 北京生命科学研究所 [National Institute of Biological Sciences (NIBS)], Beijing, China (45 min).
• 10/26/2012: The US NIH/NIAID Integrated Research Facility at Fort Detrick (IRF-Frederick) – Capabilities and Opportunities for Collaboration. Presented at 中国科学院第五届新生病毒性疾病控制学术研讨会 [The 5th Symposium on Emerging Viral Diseases], October 24-27, Wǔhàn, Húběi Province, China (35 min).
• 10/25/2012: Virion-like Particles as a Platform for Vaccines against Ebola- and Marburg viruses. Presented at 中国科学院第五届新生病毒性疾病控制学术研讨会 [The 5th Symposium on Emerging Viral Diseases], October 24-27, Wǔhàn, Húběi Province, China (35 min).
• 09/14/2012: Novel Science and Social Science Approaches to Assess Biotechnology and Bioweapons Threats - Literature Analysis as the Basis for Biological Threat Assessments. Lecture presented at the US-UK Joint Workshop on Improving Intelligence Analysis for Emerging Biotechnology Threats, September 12-14, London, UK (20 min + 60 min discussion).
• 07/23/2012: Barriers to Bioweapons – The Case of Filoviruses. Lecture presented as part of the Summer Professional Course HSEC300 “Pandemics, Bioterrorism, and International Security”, July 23-25, George Mason University, Fairfax, Virginia, USA (120 min).
• 11/01/2011: Examples for Successful International Collaborations: US-Russia 2001. International Engagement: Responsible Bioscience for a Safe and Secure Society. Workshop three organized by the American Association for Advancement in Science and the Institut Pasteur de Tunis, October 31 – November 1, Tunis, Tunisia (15 min). → See http://www.aaas.org/cstsp/publications/
• 08/08/2011: Simian hemorrhagic fever virus as a model for human viral hemorrhagic fevers under biosafety level 2 conditions. «ФУНДАМЕНТАЛЬНЫЕ И ПРИКЛАДНЫЕ АСПЕКТЫ МЕДИЦИНСКОЙ ПРИМАТОЛОГИИ» - Второй международной научной конференции [2nd international conference “Fundamental and applied aspects of medical primatology”], August 8-10, Sochi-Adler, Krasnodar Krai, Russia. (20 min)
• 07/26/2011: Barriers to Bioweapons – The Case of the Filoviruses. Lecture presented as part of the MIT Summer Professional Program 17.60s “Pandemics and Bioterrorism: From Realistic Threats to Effective Policies”, July 25-27, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA (120 min).
• 05/26/2011: Mining the Filovirus Bibliome - Important Insights Gained from Analyzing Literature Not Indexed in PubMed. Uniformed Services University of the Health Sciences (USUHS), Department of Medical History, Bethesda, Maryland, USA (60 min)
• 05/24/2011: Science and Security – Friends or Foes? American Association for the Advancement of Science (AAAS) Center for Science, Technology, and Security Policy Monthly DC Biosecurity Meeting, Washington, DC, USA (15 min + 60 min discussion)
• 05/06/2011: Marburg and Ebola viruses – myths, facts, and fiction. South Dakota State University, Sioux City, South Dakota, USA (90 min + discussion)
• 04/20/2011: Filoviruses, Bioweapons Development, and Arms Control. Guest lecture for class BSOC 4711, "The Dark Side of Biology: Biological Weapons, Bioterrorism, and Biocriminality", Cornell-in-Washington, Washington, DC, USA (120 min)
• 03/24/2011: Filoviruses in the NIH Work Environment. Special OMS [Occupational Medical Services] Seminar. National Institutes of Health (NIH), Bethesda, Maryland, USA (90 min)
• 07/27/2010: Barriers to Bioweapons – The Case of the Filoviruses. Lecture presented as part of the MIT Summer Professional Program 17.60s “Pandemics and Bioterrorism: From Realistic Threats to Effective Policies”, July 26-28, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA (120 min).
• 04/21/2010: Ebolavirus Δ-Peptides Modulate Filovirus Cell Entry. 5th International Symposium on Filoviruses, April 18-21, Sheraton Miyako Hotel, Tokyo, Japan (15 min)
• 04/08/2010: Discussion of Three New Books on Biological Weapons Science and Policy - Filoviruses: A Compendium of 40 Years of Epidemiological, Clinical, and Laboratory Studies. Sponsored by the Monterey Institute and George Washington University. The Stimson Center, Washington, DC, USA (10 min + 90 min discussion).
• 12/16/2009: Increasing Transparency Through Scientific Collaboration - The Transformation of a Former USSR Bioweapons Laboratory. Technische Universität Darmstadt [Technical University Darmstadt], Darmstadt, Hesse, Germany (20 min + 20 min discussion).
• 12/16/2009: Preventing the Misuse of Gene/Genome Synthesis – Is It Possible and Necessary? Technische Universität Darmstadt [Technical University Darmstadt], Darmstadt, Hesse, Germany (20 min + 20 min discussion).
• 07/27/2009: Barriers to Bioweapons – The Case of the Filoviruses. Lecture presented as part of the MIT Summer Professional Program 17.60s “Pandemics and Bioterrorism: From Realistic Threats to Effective Policies”, July 27-29, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA (120 min).
• 07/11/2009: Ebolaviral Δ-Peptides Interfere with Filovirus Cell Entry. 28th Annual Meeting of the American Society for Virology, July 11-15, The University of British Columbia, Vancouver, British Columbia, Canada (15 min).
• 11/11/2008: Alternatives to Having a Regular Career in Virology – How important is Background Diversity? Istituto di Ricerca in Biomedicina Annual Student Retreat 2008, Hof de Planis, Switzerland (90 min).
• 07/12/2008: Receptor determinants of zoonotic transmission of New World hemorrhagic fever arenaviruses. 27th Annual Meeting of the American Society for Virology, July 12-16, Ithaca, New York, USA (15 min).
• 11/08/2007: Marburg- and Ebolaviruses – Myths, Facts, and Threats. An Open-source Analysis. Biological Threat Characterization Center (BTCC), National Biodefense Analysis and Countermeasures Center (NBACC), Frederick, Maryland, USA (120 min)
• 10/19/2007: Open-source Analysis: Lessons from “Ebola.” Transparency and Secrecy in Biodefense and Dualuse Life Sciences Research – Past and Present Practices, October 19, George Mason University, Arlington, Virginia, USA (15 min)
• 09/05/2007: Filoviral Receptor-Binding Domains are Promising Subunit Vaccine Candidates. Third European Congress of Virology, September 1-5, CCN CongressCenter Nürnberg, Nuremberg, Bavaria, Germany (15 min).
• 07/24/2007: Barriers to Bioweapons – The Case of the “Ebola virus”. Lecture presented as part of the MIT Summer Professional Program 17.60s “Combating Bioterrorism / Pandemics: Implementing Policies for Biosecurity”, July 23-25, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA (120 min).
• 05/08/2007: Maximum Containment Facilities – Sense and Nonsense, Risks and Benefits. MIT Faculty Dinner Series on Biosecurity, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA (60 min)
• 04/17/2007: Filoviral Receptor-Binding Domains are Promising Subunit Vaccine Candidates. 4th Annual NIAID [National Institute of Allergy and Infectious Diseases] RCE [Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases] Research Meeting, April 15-17, Hyatt Regency Hotel at Union Station, St. Louis, Missouri, USA (15 min).
• 02/12/2007: Entry-inhibitory effects of filoviral receptor-binding domains and soluble glycoproteins. United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, Maryland, USA (60 min).
• 10/30/2006: Determination and Evaluation of Filoviral Receptor-binding Domains (RBDs) and RBD-containing Soluble Glycoproteins as Possible Inhibitors of Infection and Vaccine Candidates. NERCE/BEID [New England Regional Center of Excellence/Biodefense and Emerging Infectious Diseases] and NBC [Northeast Biodefense Center] Third Annual Retreat, October 29-31, The Sagamore on Lake George at Bolton Landing, New York, USA (15 min).
• 10/27/2006: Integration of Former Soviet Biowarfare Facilities into the International Research Community. Success or Failure? Princeton University Carnegie Biodefense Seminar, Woodrow Wilson School of Public and International Affairs, Princeton University, Princeton, New Jersey, USA (90 min).
• 07/25/2006: Barriers to Bioweapons – The Case of the “Ebola virus”. Lecture presented as part of the MIT Summer Professional Program 17.60s “Combating Bioterrorism / Pandemics: Implementing Policies for Biosecurity”, July 24-26, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA (105 min).
• 07/16/2006: Lake Victoria marburgvirus and Zaire ebolavirus attach to a common cell-entry factor. American Society for Virology 25th Annual Meeting – SCIENTIFIC PROGRAM & ABSTRACTS, July 15-19, Monona Terrace Convention Center, University of Wisconsin-Madison, Madison, Wisconsin, USA (15 min).
• 03/30/2006: Bioengineered Threats – Facts and Fiction. Dartmouth Medical School, Hanover, New Hampshire, USA (120 min).
• 03/27/2006: Conserved Receptor-Binding Domains of Filoviruses Bind a Common Receptor. Regional Centers for Biodefense and Emerging Infectious Diseases Research Third Annual Meeting, March 26-28, Sheraton New York Hotel and Towers, New York City, New York, USA (15 min).
• 11/15/2005: Marburgviruses and Ebolaviruses – Filoviruses and Pop Culture. Massachusetts Institute of Technology Lincoln Laboratory, Lexington, Massachusetts, USA (120 min).
• 11/07/2005: Lake Victoria marburgviruses and Zaire Ebolaviruses attach to a common cell-entry factor. Harvard Medical School Department of Microbiology and Molecular Genetics Monday Talk, Harvard Medical School, Boston, Massachusetts, USA (20 min).
• 10/26/2005: Lake Victoria marburgviruses and Zaire Ebolaviruses attach to a common cell-entry factor. Medizinische B-Schutz-Tagung 2005—Biological Medical Defense Conference 2005, October 26-27, Ernst-von- Bergmann Kaserne [Ernst-von-Bergmann barracks], Munich, Bavaria, Germany (20 min).
• 10/21/2005: Qualitative and Quantitative Assessment of the “Dangerous Activities” Categories Defined by the CISSM Controlling Dangerous Pathogens Project. Workshop on Protective Oversight of Dual-Use Research, October 21. American Academy of Arts and Sciences, and Center for International and Security Studies at Maryland (CISSM), Cambridge, Massachusetts, USA (20 min + 40 min discussion).
• 09/29/2005: Marburgviruses and Ebolaviruses – History, Fiction, and the Facts. MIT Faculty Dinner Series on Biosecurity, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA (45 min)
• 08/26/2004: Global Biosecurity – Oversight, International Collaboration and Integration of Scientists to Prevent Biological Weapons Attacks. Session Infectious Disease in an Expanding Europe, organized by Alison Abbott, Nature, Germany. EuroScience Open Forum 2004 – First Pan-European General Science Meeting, August 25-28, Stockholm, Sweden (30 min, plus round table discussion with Stefan Kaufmann, Ragnar Norrby, Albert Osterhaus, and Hans Wigzell, plus international press conference).
• 12/01/2002: Where to go to learn (enhancing global biosecurity). Symposium “Facing the Threat by Intentionally Spread Microorganisms”, November 30 – December 1, Institut für Infektionsmedizin [Institute of Medicine of Infection], Universitätsklinikum Benjamin Franklin [Benjamin Franklin Medical Center], Freie Universität Berlin, Germany (20 min).
• 03/12/2002: In German: Umstellung von militärischer auf zivile Forschung am Beispiel eines russischen BWaffen-Labors [A Russian bioweapons laboratory as an example for conversion of military to civilian research]. Infotag B-Waffen – Wie ernst ist die Gefahr? [Briefing bioweapons – How serious is the threat?], DECHEMA e.V. – Gesellschaft für Chemische Technik und Biotechnologie [DECHEMA – Society for chemical technology and biotechnology], Ausschuss „Biotechnologie und Gesellschaft“ [Panel “Biotechnology and society”], Taunustor Conference Center, Frankfurt am Main, Hesse, Germany (35 min).
• 11/07/2001: In German: Erste Schritte in Richtung eines Wissenschaftleraustauschs mit ehemaligen Biowaffenlaboratorien Russlands im Rahmen internationaler Abrüstungsbemühungen [First steps towards an exchange of researchers with former Russian bioweapons laboratories within international disarmament efforts] (30min). Bioterrorismus – Wissenschaftliche Sondersitzung in Zusammenarbeit mit der Ärztekammer Berlin, UKBF der Freien Universität Berlin, der Berliner Mikrobiologischen Gesellschaft und der Berliner Wissenschaftlichen Gesellschaft [Bioterrorism – Scientific special session in collaboration with the chamber of medical doctors of Berlin, the university hospital Benjamin Franklin of Freie Universität Berlin, the Berlin society of microbiology, and the Berlin society of science], Universitätsklinikum Benjamin Franklin, Freie Universität Berlin, Berlin, Germany (20 min).
• 07/19/2000: In German: Biologische Kriegsführung und Bioterrorismus [Biological warfare and bioterrorism]. Freie Universität Berlin, Germany, Department of Infectious Diseases Lecture Series for Medical Students (90min).
• 05/30/2000: In German: Ebola- und Marburg-Viren als Beispiele für den Mißbrauch biologischer Erkenntnisse [Ebola and Marburg viruses as examples for the misuse of biological knowledge]. Freie Universität Berlin, Germany, Department of Infectious Diseases Seminar Series (60min).

Public Outreach:

Books:

Edited Books:

1. Shapshak, Paul, John Sinnott, Charurut Somboonwit, and Jens H. Kuhn (eds.). 2014. Global Virology. Springer, New York, New York, USA. In press.
2. Kuhn, Jens H. and Sina Bavari (eds.) 2013. Advances in Filovirus Research 2012. MDPI, Basel, Switzerland.

Other Publications:

1. Janosko, Krisztina, Michael R. Holbrook, Jason Barr, Laura Bollinger, Je T’aime Newton, Corrie Ntiforo, Linda Coe, Lisa E. Hensley, Peter B. Jahrling, Jens H. Kuhn, and Matthew G. Lackemeyer. 2014. Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 1. Biosafety level 4 suit laboratory suite entry and exit procedures. JoVE - Journal of Visualized Experiments (Boston). In press.
2. Borca, Manuel, Cyril Gay, Guillermo Risatti, Donald O’Toole, Hong Li, Jens H. Kuhn, Charles E. Lewis, Christina Loiacono, and David White. 2014. Viral Hemorrhagic Fevers of Animals Caused By DNA Viruses. In Shapshak, Paul, John Sinnott, Charurut Somboonwit, and Jens H. Kuhn (eds.). Global Virology. Springer, New York, New York, USA. In press.
3. Honko, Anna N., Peter B. Jahrling, Jens H. Kuhn, Sheli R. Radoshitzky, and Joshua C. Johnson. 2014. Arenaviruses. In Shapshak, Paul, John Sinnott, Charurut Somboonwit, and Jens H. Kuhn (eds.). Global Virology. Springer, New York, New York, USA. In press.
4. Falk, Knut, Maria Aamelfot, Ole Bendik Dale, Theodore R. Meyers, Sally Ann Iverson, William R. White, Laura Bollinger, Peter B. Jahrling, Jens H. Kuhn, Charles Lewis, Christina Loiacono, and David White. 2014. Viral Hemorrhagic Fevers of Animals Caused By Negative-Stranded RNA Viruses. In In Shapshak, Paul, John Sinnott, Charurut Somboonwit, and Jens H. Kuhn (eds.). Global Virology. Springer, New York, New York, USA. In press.
5. Van Campen, Hana, Guillermo Risatti, Manuel Borca, Peter Kerr, Tanja Strive, Peter B. Jahrling, Jens H. Kuhn, Charles E. Lewis, Christina M. Loiacono, and David White. 2014. Viral Hemorrhagic Fevers of Animals Caused By Positive-Stranded RNA Viruses. In In Shapshak, Paul, John Sinnott, Charurut Somboonwit, and Jens H. Kuhn (eds.). Global Virology. Springer, New York, New York, USA. In press.
6. Miller, Myrna, William Lagreid, Jens H. Kuhn, Charles E. Lewis, Christina Loiacono, and David White. 2014. Viral Hemorrhagic Fevers of Animals Caused by Double-Stranded RNA Viruses. In Shapshak, Paul, John Sinnott, Charurut Somboonwit, and Jens H. Kuhn (eds.). Global Virology. Springer, New York, New York, USA. In press.
7. Carocci, Margot, Jens H. Kuhn, Priscilla L. Yang. Flaviviruses – Introduction to Dengue viruses. In Shapshak, Paul, John Sinnott, Charurut Somboonwit, and Jens H. Kuhn (eds.). Global Virology. Springer, New York, New York, USA. In press.
8. Kindrachuk, Jason, Jens H. Kuhn, and Peter B. Jahrling. The Role of Viral Protein Phosphorylation During Filovirus Infection. In Shapshak, Paul, John Sinnott, Charurut Somboonwit, and Jens H. Kuhn (eds.). Global Virology. Springer, New York, New York, USA. In press.
9. Whitehouse, Chris, Jens H. Kuhn, Jiro Wada, and Koray Ergunay. Family Bunyaviridae. In Shapshak, Paul, John Sinnott, Charurut Somboonwit, and Jens H. Kuhn (eds.). Global Virology. Springer, New York, New York, USA. In press.
10. Kuhn, Jens H., and Clarence J. Peters. Arthropod-borne and Rodent-Borne Virus Infections, chapter 233. In Kasper, Dennis L., Anthony S. Fauci, Stephen L. Hauser, Dan L. Longo, J. Larry Jameson, and Joseph Loscalzo (eds.), Harrison’s Principles of Internal Medicine, 19th edition, vol. 2. In press.
11. Kuhn, Jens H. Ebolaviruses and Marburgviruses, chapter 234. In Kasper, Dennis L., Anthony S. Fauci, Stephen L. Hauser, Dan L. Longo, J. Larry Jameson, and Joseph Loscalzo (eds.), Harrison’s Principles of Internal Medicine, 19th edition, vol. 2. In press.
12. Kugelman, Jeffrey R., Mariano Sanchez-Lockhart, Kristian G. Andersen, Stephen Gire, Daniel J. Park, Rachel Sealfon, Aaron E. Lin, Shirlee Wohl, Pardis C. Sabeti, Jens H. Kuhn, and Gustavo F. Palacios. 2015. Evaluation of the Potential Impact of Ebola Virus Genomic Drift on the Efficacy of Sequence-Based Candidate Therapeutics. mBIO (Washington, DC) 6(1): e02227-14 [Epub Jan. 20, 2015].
13. Kuhn, Jens H., John Misasi John, Peter Jahrling, and James Lawler. 2014. Marburgviruses and Ebolaviruses. In Southwick, Frederick S., Bernard Hirschel, Adolf W. Karchmer, Carol A. Kauffman, and Richard P. Wenzel (eds.). CDS:ID [Clinical Decision Support: Infectious Diseases], 2nd ed. Decision Support in Medicine, LLC. Wilmington, Delaware, USA. https://www.decisionsupportinmedicine.com
14. Kindrachuk, Jason, Britini Ork, Brit J. Hart, Steven Mazur, Michael R. Holbrook, Matthew B. Frieman, Dawn Traynor, Reed F. Johnson, Julie Dyall, Jens H. Kuhn, Gene G. Olinger, Lisa E. Hensley, and Peter B. Jahrling. 2015. The Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for MERS-CoV Infection as Identified by Temporal Kinome Analysis. Antimicrobial Agents and Chemotherapy (Washington, DC) [Epub Dec. 8, 2014]. PMID: 25487801.
15. Kuhn, Jens H., Ralf Dürrwald, Yīmíng Bào, Thomas Briese, Kathryn Carbone, Anna N. Clawson, Joseph L. deRisi, Wolfgang Garten, Peter B. Jahrling, Jolanta Kolodziejek, Dennis Rubbenstroth, Martin Schwemmle, Mark Stenglein, Keizo Tomonaga, Herbert Weissenböck, and Norbert Nowotny. 2015. Taxonomic reorganization of the family Bornaviridae. Archives of Virology (Vienna) [Epub Dec. 2, 2014]. PMID: 25449305.
16. Kuhn, Jens H., Kristian G. Andersen, Sylvain Baize, Yīmíng Bào, Sina Bavari, Nicolas Berthet, Olga Blinkova, J. Rodney Brister, Anna N. Clawson, Joseph Fair, Martin Gabriel, Robert F. Garry, Stephen K. Gire, Augustine Goba, Jean-Paul Gonzalez, Stephan Günther, Christian T. Happi, Peter B. Jahrling, Jimmy Kapetshi, Gary Kobinger, Jeffrey R. Kugelman, Eric M. Leroy, Gael Darren Maganga, Placide K. Mbala, Lina M. Moses, Jean-Jacques Muyembe-Tamfum, Magassouba N’Faly, Stuart T. Nichol, Sunday A. Omilabu, Gustavo Palacios, Daniel J. Park, Janusz T. Paweska, Sheli R. Radoshitzky, Cynthia A. Rossi, Pardis C. Sabeti, John S. Schieffelin, Randal J. Schoepp, Rachel Sealfon, Robert Swanepoel, Jonathan S. Towner, Jiro Wada, Nadia Wauquier, Nathan L. Yozwiak, and Pierre Formenty. 2014. Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014. Viruses (Basel) 6(11): 4760-4799 [Epub Nov. 24, 2014].
17. Kuhn, Jens H., Loreen L. Lofts, Jeffrey R. Kugelman, Sophie J. Smither, Mark S. Lever, Guido van der Groen, Karl M. Johnson, Sheli R. Radoshitzky, Sina Bavari, Peter B. Jahrling, Jonathan S. Towner, Stuart T. Nichol, and Gustavo Palacios. 2014. Reidentification of Ebola virus E718 and ME as Ebola virus/H.sapienstc/ COD/1976/Yambuku-Ecran. Genome Announcements (Washington, DC) 2(6): e01178-14 [Epub Nov. 20, 2014]. PMID: 25414499.
18. Caì, Yíngyún, Shuǐqìng Yú, Elena N. Postnikova, Steven Mazur, John G. Bernbaum, Robin Burk, Téngfēi Zhāng, Sheli R. Radoshitzky, Marcel A. Müller, Ingo Jordan, Laura Bollinger, Lisa E. Hensley, Peter B. Jahrling, and Jens H. Kuhn. 2014. CD26/DPP4 Cell-surface Expression in Bat Cells Correlates with Bat Cell Susceptibility to Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection and Evolution of Persistent Infection. PLoS [Public Library of Science] ONE (San Francisco) 9(11): e112060 [Epub Nov. 19, 2014]. PMID: 25409519.
19. Kuhn Jens H., and John P. Woodall. 2014. Ebola Virus Disease. In Wertheim, Heiman F. L., Peter Horby, John P. Woodall, and Simon I. Hay (eds.). Atlas of Human Infectious Diseases. Wiley-Blackwell Publishing, Hoboken, New Jersey, USA. [Online.] www.infectionatlas.com [10/31/2014, last accessed.]
20. Kuhn Jens H., and John P. Woodall. 2014. Marburg Virus Disease. In Wertheim, Heiman F. L., Peter Horby, John P. Woodall, and Simon I. Hay (eds.). Atlas of Human Infectious Diseases. Wiley-Blackwell Publishing, Hoboken, New Jersey, USA. [Online.] www.infectionatlas.com [10/31/2014, last accessed.]
21. Caì, Yíngyún, Elena N. Postnikova, John G. Bernbaum, Shuīqìng Yú, Steven Mazur, Nicole M. Deiuliis, Sheli R. Radoshitzky, Matthew G. Lackemeyer, Adam McCluskey, Phillip J. Robinson, Volker Haucke, Victoria Wahl-Jensen, Adam L. Bailey, Michael Lauck, Thomas C. Friedrich, David H. O’Connor, Tony L. Goldberg, Peter B. Jahrling, and Jens H. Kuhn. 2015. Simian Hemorrhagic Fever Virus Cell Entry Is Dependent on CD163 and Uses a Clathrin-Mediated Endocytosis-Like Pathway. Journal of Virology (Washington, DC) 89(1): 844-856 [Epub Oct. 29, 2014]. PMID: 25355889.
22. Ng, Melinda, Esther Ndungo, Rohit K. Jangra, Yingyun Cai, Elena Postnikova, Sheli R. Radoshitzky, John M. Dye, Eva Ramírez de Arellano, Ana Negredo, Gustavo Palacios, Jens H. Kuhn, and Kartik Chandran. 2014. Cell entry by a novel European filovirus requires host endosomal cysteine proteases and Niemann-Pick C1. Virology (New York) 468-470(11): 637-646 [Epub Oct. 10, 2014]. PMID: 25310500.
23. Lauck, Michael, Gustavo Palacios, Michael R. Wiley, Yànhuá Lǐ, Yīng Fāng, Matthew G. Lackemeyer, Yíngyún Caì, Adam L. Bailey, Elena Postnikova, Sheli R. Radoshitzky, Reed F. Johnson, Sergey V. Alkhovsky, Petr G. Deriabin, Thomas C. Friedrich, Tony L. Goldberg, Peter B. Jahrling, David H. O’Connor, and Jens H. Kuhn. 2014. Genome Sequences of Simian Hemorrhagic Fever Virus Variant NIH LVR42-0/M6941 Isolates (Arteriviridae: Arterivirus). Genome Announcements (Washington, DC) 2(5): e00978-14 [Epub Oct. 9, 2014]. PMID: 25301647. PMCID: PMC4192379.
24. Kuhn, Jens H., Kristian G. Andersen, Yīmíng Bào, Sina Bavari, Stephan Becker, Richard S. Bennett, Nicholas H. Bergman, Olga Blinkova, Steven Bradfute, J. Rodney Brister, Alexander Bukreyev, Kartik Chandran, Alexander A. Chepurnov, Robert A. Davey, Ralf G. Dietzgen, Norman A. Doggett, Olga Dolnik, John M. Dye, Sven Enterlein, Paul W. Fenimore, Pierre Formenty, Alexander N. Freiberg, Robert F. Garry, Nicole L. Garza, Stephen K. Gire, Jean-Paul Gonzalez, Anthony Griffiths, Christian T. Happi, Lisa E. Hensley, Andrew S. Herbert, Michael C. Hevey, Thomas Hoenen, Anna N. Honko, Georgy M. Ignatyev, Peter B. Jahrling, Joshua C. Johnson, Karl M. Johnson, Jason Kindrachuk, Hans-Dieter Klenk, Gary Kobinger, Tadeusz J. Kochel, Matthew G. Lackemeyer, Daniel F. Lackner, Eric M. Leroy, Mark S. Lever, Elke Mühlberger, Sergey V. Netesov, Gene G. Olinger, Sunday A. Omilabu, Gustavo Palacios, Rekha G. Panchal, Daniel J. Park, Jean L. Patterson, Janusz T. Paweska, Clarence J. Peters, James Pettitt, Louise Pitt, Sheli R. Radoshitzky, Elena I. Ryabchikova, Erica Ollmann Saphire, Pardis C. Sabeti, Rachel Sealfon, Aleksandr M. Shestopalov, Sophie J. Smither, Nancy J. Sullivan, Robert Swanepoel, Ayato Takada, Jonathan S. Towner, Guido van der Groen, Viktor E. Volchkov, Valentina A. Volchkova, Victoria Wahl-Jensen, Travis K. Warren, Kelly L. Warfield, Manfred Weidmann and Stuart T. Nichol. 2014. Filovirus RefSeq Entries: Evaluation and Selection of Filovirus Type Variants, Type Sequences, and Names. Viruses (Basel) 6(9): 3663-3682 [Epub Sep. 26, 2014]. PMID: 25256396.
25. 25. Bailey, Adam L. , Michael Lauck, Samuel D. Sibley, Jerilyn Pecotte, Karen Rice, Geoffrey Weny, Alex Tumukunde, David Hyeroba, Justin Greene, Michael Correll, Michael Gleicher, Thomas C. Friedrich, Peter B. Jahrling, Jens H. Kuhn, Tony L. Goldberg, Jeffrey Rogers, and David H. O’Connor. 2014. Two Novel Simian Arteriviruses in Captive and Wild Baboons (Papio spp.). Journal of Virology (Washington, DC) 88(22): 13231-13238 [Epub Sep. 3, 2014]. PMID: 25187550.
26. Poole, Daniel S., Shuĭqìng Yú, Yíngyún Caì, Jorge M. Dinis, Marcel A. Müller, Ingo Jordan, Thomas C. Friedrich, Jens H. Kuhn, and Andrew Mehle. 2014. Influenza A Virus Polymerase Is a Site for Adaptive Changes During Experimental Evolution in Bat Cells. Journal of Virology (Washington, DC) 88(21): 12572-12585 [Epub Aug. 20, 2014]. PMID: 25142579.
27. Bao, Yiming, Michael J. Buchmeier, Remi Charrel, Christopher S. Clegg, Juan Carlos de la Torre, Sebastien Emonet, Jean-Paul Gonzales, Jens H. Kuhn, Igor S. Lukashevich, Clarence J. Peters, Sheli R. Radoshitzky, Victor Romanowski, and Maria S. Salvato. 2014. Two (2) new species in the genus Arenavirus (proposed separately to be renamed Mammarenavirus), family Arenaviridae. ICTV [International Committee for Taxonomy of Viruses] Proposal (Taxoprop) No. 2014.013aV. http://talk.ictvonline.org/files/proposals/taxonomy_proposals_vertebrate1/m/vert01/4922.aspx [Epub July 3, 2014].
28. Buchmeier, Michael J., Remi Charrel, Christopher S. Clegg, Juan Carlos de la Torre, Sebastien Emonet, Jean-Paul Gonzales, Jens H. Kuhn, Igor S. Lukashevich, Clarence J. Peters, Sheli R. Radoshitzky, Victor Romanowski, and Maria S. Salvato. 2014. Rename one (1) genus and twenty-five (25) species in the family Arenaviridae. ICTV [International Committee for Taxonomy of Viruses] Proposal (Taxoprop) No. 014.012aV. http://talk.ictvonline.org/files/proposals/taxonomy_proposals_vertebrate1/m/vert01/4927.aspx [Epub July 3, 2014].
29. Kuhn, Jens H., Ralf Dürrwald, Yiming Bao, Thomas Briese, Kathryn Carbone, Anna N. Clawson, Wolfgang Garten, Peter B. Jahrling, Jolanta Kolodziejek, Dennis Rubbenstroth, Martin Schwemmle, Keizo Tomonaga, Herbert Weissenböck, and Norbert Nowotny. 2014. 4 new species in the genus Bornavirus; renaming of 1 species in the genus Bornavirus; and renaming of the family Bornaviridae. ICTV [International Committee for Taxonomy of Viruses] Proposal (Taxoprop) No. 014.010a,bV. http://talk.ictvonline.org/files/proposals/taxonomy_proposals_vertebrate1/m/vert01/4918.aspx [Epub July 2, 2014].
30. Dietzgen, Ralf G., Jens H. Kuhn, Anna N. Clawson, Juliana Freitas-Astúa, Michael M. Goodin, Elliott W. Kitajima, Hideki Kondo, Thierry Wetzel, and Anna E. Whitfield. 2014. Create 2 species, Orchid fleck dichorhavirus and Coffee ringspot dichorhavirus, in a new unassigned genus, Dichorhavirus. ICTV [International Committee for Taxonomy of Viruses] Proposal (Taxoprop) No. 2014.003a-dV. http://talk.ictvonline.org/files/proposals/taxonomy_proposals_vertebrate1/m/vert01/4883.aspx [Epub June 23, 2014].
31. Ladner, Jason T., Brett Beitzel, Patrick S. G. Chain, Matthew G. Davenport, Eric F. Donaldson, Matthew Frieman, Jeffrey R. Kugelman, Jens H. Kuhn, Julian O’Rear, Pardis C. Sabeti, David E. Wentworth, Michael R. Wiley, Guo-Yun Yu, The Threat Characterization Consortium, Shanmuga Sozhamannan, Christopher Bradburne, and Gustavo Palacios. 2014. Standards for Sequencing Viral Genomes in the Era of High-Throughput Sequencing. mBIO (Washington, DC) 5(3): e01360-14 [Epub Jun. 17, 2014]. PMID: 24939889.
32. Zro, K., S. Azelmat, Y. Bendouro, J. H. Kuhn, E. El Fahime, and M. M. Ennaji. 2014. PCR-based assay to diagnose sheeppox virus in ocular, nasal, and rectal swabs of infected Moroccan sheep. Journal of Virological Methods (Amsterdam) 204C: 38-43 [Epub March 31, 2014]. PMID: 24698762.
33. Jahrling, Peter B., Lauren Keith, Marisa St. Claire, Reed F. Johnson, Laura Bollinger, Matthew G. Lackemeyer, Lisa E. Hensley, Jason Kindrachuk, and Jens H. Kuhn. 2014. The NIAID Integrated Research Facility at Frederick, Maryland: a unique international resource to facilitate medical countermeasure development for BSL-4 pathogens. Pathogens and Disease (Malden) 71(2): 211-216. [Epub Mar. 29, 2014]. PMID: 24687975.
34. 34. Bailey, Adam L., Michael Lauck, Andrea Weiler, Samuel D. Sibley, Jorge M. Dinis, Zachary Bergman,
35. Chase W. Nelson, Michael Correll, Michael Gleicher, David Hyeroba, Alex Tumukunde, Geoffrey Weny,
36. Colin Chapman, Jens H. Kuhn, Austin L. Hughes, Thomas C. Friedrich, Tony L. Goldberg, and David H.
37. O’Connor. 2014. High Genetic Diversity and Adaptive Potential of Two Simian Hemorrhagic Fever Viruses in a
38. Wild Primate Population. PLoS [Public Library of Science] ONE (San Francisco) 9(3): e90714 [Epub March 20,
39. 2014]. PMID: 24651479. PMCID: PMC3961216.
40. 35. Kindrachuk, Jason, Shane Falcinelli, Jiro Wada, Jens H. Kuhn, Lisa E. Hensley, and Peter B. Jahrling.
41. 2014. Systems kinomics for characterizing host responses to high-consequence pathogens at the NIH/NIAID
42. Integrated Research Facility-Frederick. Pathogens and Disease (Malden) 71(2): 188-196. [Epub Mar. 2, 2014].
43. PMID: 24585711.
44. 36. Kuhn, Jens H., Yīmíng Bào, Sina Bavari, Stephan Becker, Steven Bradfute, Kristina Brauburger, J.
45. Rodney Brister, Alexander A. Bukreyev, Yíngyún Caì, Kartik Chandran, Robert A. Davey, Olga Dolnik,
46. John M. Dye, Sven Enterlein, Jean-Paul Gonzalez, Pierre Formenty, Alexander N. Freiberg, Lisa E.
47. Hensley, Thomas Hoenen, Anna N. Honko, Georgy M. Ignatyev, Peter B. Jahrling, Karl M. Johnson,
48. Heinz-Dieter Klenk, Gary Kobinger, Matthew G. Lackemeyer, Eric M. Leroy, Mark S. Lever, Elke
49. Mühlberger, Sergey V. Netesov, Gene G. Olinger, Gustavo Palacios, Jean L. Patterson, Janusz T. Paweska,
50. Louise Pitt, Sheli R. Radoshitzky, Elena I. Ryabchikova, Erica Ollmann Saphire, Aleksandr M.
51. Shestopalov, Sophie J. Smither, Nancy J. Sullivan, Robert Swanepoel, Ayato Takada, Jonathan S. Towner,
52. Guido van der Groen, Viktor E. Volchkov, Valentina A. Volchkova, Victoria Wahl-Jensen, Travis K.
53. Warren, Kelly L. Warfield, Manfred Weidmann, and Stuart T. Nichol. 2014. Virus nomenclature below the
54. species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA. Archives of
55. Virology (Vienna) 159(5): 1229-1237 [Epub Nov. 5, 2013]. PMID: 24190508.
56. 37. Bukreyev, Alexander A., Kartik Chandran, Olga Dolnik, John M. Dye, Hideki Ebihara, Eric M. Leroy,
57. Elke Mühlberger, Sergey V. Netesov, Jean L. Patterson, Janusz T. Paweska, Erica Ollmann Saphire,
58. Sophie J. Smither, Ayato Takada, Jonathan S. Towner, Travis Warren, and Jens H. Kuhn. 2014.
59. Discussions and decisions of the 2012-2014 International Committee on Taxonomy of Viruses (ICTV)
60. Filoviridae Study Group, January 2012-June 2013. Archives of Virology (Vienna) 159(4): 821-830 [Epub Oct.
61. 13, 2013]. PMID: 24122154.
62. 38. Lackemeyer, Matthew G., Fabian de Kok-Mercado, Jiro Wada, Laura Bollinger, Jason Kindrachuk,
63. Victoria Wahl-Jensen, Jens H. Kuhn, and Peter B. Jahrling. 2014. ABSL-4 Aerobiology Biosafety and
64. Technology at the NIH/NIAID Integrated Research Facility at Fort Detrick. Viruses (Basel) 6(1): 137-150 [Epub
65. Dec. 7, 2014]. PMID: 24402304.
66. 39. Caì, Yíngyún, Shuĭqìng Yú, Steven Mazur, Lián Dǒng, Krisztina Janosko, Téngfēi Zhāng, Marcel A.
67. Müller, Lisa E. Hensley, Sina Bavari, Peter B. Jahrling, Sheli R. Radoshitzky, and Jens H. Kuhn. 2013.
68. Nonhuman transferrin receptor 1 is an efficient cell entry receptor for Ocozocoautla de Espinosa virus. Journal of
69. Virology (Washington, DC) 87(24): 13930-13935 [Epub Oct. 9, 2013]. PMID: 24109228. PMCID:
70. PMC3838296.
71. 40. Dietzgen, Ralf G., Jens H. Kuhn, Anna N. Clawson, Juliana Freitas-Astúa, Michael M. Goodin, Elliott W.
72. Kitajima, Hideki Kondo, Thierry Wetzel, and Anna E. Whitfield. 2014. Dichorhavirus: a proposed new
73. genus for Brevipalpus mite-transmitted, nuclear, bacilliform, bipartite, negative-strand RNA plant viruses.
74. Archives of Virology (Vienna) 159(3): 607-619 [Epub Oct. 1, 2013]. PMID: 24081823.
75. 41. Kuhn, Jens H. 2013. Virus nomenclature, pp. 63-65 (chapter 2.4). In Smart, Pippa, Hervé Maisonneuve, and
76. Arjan Polderman (eds.). Science Editors’ Handbook, 2nd ed. European Association of Science Editors (EASE),
77. London, United Kingdom.
78. 42. Bradfute, Steven B., Sina Bavari, Peter B. Jahrling, and Jens H. Kuhn. 2013. Marburg Virus Disease, pp.
79. 457-479 (chapter 25). In Sunit K. Singh and Daniel Ruzek (eds.). Viral Hemorrhagic Fevers. Taylor &
80. Francis/CRC Press, Boca Raton, Florida, USA.
81. 43. Radoshitzky, Sheli R., Fabian de Kok-Mercado, Peter B. Jahrling, Sina Bavari, and Jens H. Kuhn. 2013.
82. “Venezuelan” Hemorrhagic Fever, pp. 359-377 (chapter 20). In Sunit K. Singh and Daniel Ruzek (eds.). Viral
83. Hemorrhagic Fevers. Taylor & Francis/CRC Press, Boca Raton, Florida, USA.
84. 44. Radoshitzky, Sheli R., Fabian de Kok-Mercado, Peter B. Jahrling, Sina Bavari, and Jens H. Kuhn. 2013.
85. Bolivian Hemorrhagic Fever, pp. 339-358 (chapter 19). In Sunit K. Singh and Daniel Ruzek (eds.). Viral
86. Hemorrhagic Fevers. Taylor & Francis/CRC Press, Boca Raton, Florida, USA.
87. 45. Wahl-Jensen, Victoria, Sheli R. Radoshitzky, Fabian de Kok-Mercado, Shannon L. Taylor, Sina Bavari,
88. Peter B. Jahrling, and Jens H. Kuhn. 2013. Role of Rodents and Bats in Human Viral Hemorrhagic Fevers, pp.
89. 99-127 (chapter 7). In Sunit K. Singh and Daniel Ruzek (eds.). Viral Hemorrhagic Fevers. Taylor & Francis/CRC
90. Press, Boca Raton, Florida, USA.
91. 46. Shurtleff, Amy C., Travis K. Warren, Derek Morrow, Sheli R. Radoshitzky, Jens H. Kuhn, and Sina
92. Bavari. 2013. Animal Models of Viral Hemorrhagic Fevers, pp. 81-98 (chapter 6). In Sunit K. Singh and Daniel
93. Ruzek (eds.). Viral Hemorrhagic Fevers. Taylor & Francis/CRC Press, Boca Raton, Florida, USA.
94. 47. Huzella, Louis M., Jennifer A. Cann, Matthew Lackemeyer, Victoria Wahl-Jensen, Peter B. Jahrling, Jens
95. H. Kuhn, and Donna L. Perry. 2013. General Disease Pathology in Filoviral and Arenaviral Infections, pp. 15-
96. 29 (chapter 2). In Sunit K. Singh and Daniel Ruzek (eds.). Viral Hemorrhagic Fevers. Taylor & Francis/CRC
97. Press, Boca Raton, Florida, USA.
98. 48. Kuhn, Jens H., Anna N. Clawson, Sheli R. Radoshitzky, Victoria Wahl-Jensen, Sina Bavari, and Peter B.
99. Jahrling. 2013. Viral Hemorrhagic Fevers: History and Definitions, pp. 3-13 (chapter 1). In Sunit K. Singh and
100. Daniel Ruzek (eds.). Viral Hemorrhagic Fevers. Taylor & Francis/CRC Press, Boca Raton, Florida, USA.
101. 49. Bukreyev, Alexander A., Kartik Chandran, Olga Dolnik, John M. Dye, Hideki Ebihara, Jens H. Kuhn,
102. Eric Leroy, W. Ian Lipkin, Elke Mühlberger, Ana I. Negredo, Sergey V. Netesov, Gustavo Palacios, Jean
103. L. Patterson, Janusz T. Paweska, Erica Ollmann Saphire, Sophie J. Smither, Ayato Takada, Antonio
104. Tenorio, Jonathan Towner, Viktor E. Volchkov, and Travis K. Warren. 2013. Create genus Cuevavirus in
105. the family Filoviridae. ICTV [International Committee for Taxonomy of Viruses] Proposal (Taxoprop) No.
106. 2012.005a-dV.v2 http://talk.ictvonline.org/files/proposals/taxonomy_proposals_vertebrate1/m/vert02/4598.aspx
107. [Epub June 24, 2013].
108. 50. Garrison, Aura, Sheli R. Radoshitzky, Krishna P. Kota, Gianluca Pegoraro, Gordon Ruthel, Jens H.
109. Kuhn, Louis A. Altamura, Steven A. Kwilas, Sina Bavari, Volker Haucke, and Connie S. Schmaljohn.
110. 2013. Crimean-Congo hemorrhagic fever virus utilizes a clathrin- and early endosome-dependent entry pathway.
111. Virology (New York) 444(1-2): 45-54 [Epub June 19, 2013]. PMID: 23791227.
112. 51. Kuhn, Jens H., Sadia Bekal, Yíngyún Caì, Anna N. Clawson, Leslie L. Domier, Marieke Herrel, Peter B.
113. Jahrling, Hideki Kondo, Kris N. Lambert, Kathie A. Mihindukulasuriya, Norbert Nowotny, Sheli R.
114. Radoshitzky, Urs Schneider, Peter Staeheli, Nobuhiro Suzuki, Robert B. Tesh, David Wang, Lin-Fa Wang,
115. and Ralf G. Dietzgen. 2013. Create a family named Nyamiviridae, with 1 genus and 3 species, in the order
116. Mononegavirales. ICTV [International Committee for Taxonomy of Viruses] Proposal (Taxoprop) No.
117. 2013.002a-hV.
118. http://talk.ictvonline.org/files/proposals/taxonomy_proposals_vertebrate1/m/vert01/4529.aspx [Epub June 16,
119. 2013].
120. 52. Kuhn, Jens H., Sheli R. Radoshitzky, Sina Bavari, and Peter B. Jahrling. 2013. ICVCN text changes for
121. clarification. ICTV [International Committee for Taxonomy of Viruses] Proposal (Taxoprop) No. 2013.001a-jG.
122. http://talk.ictvonline.org/files/proposals/taxonomy_proposals_general1/m/gen01/4527.aspx [Epub June 13,
123. 2013].
124. 53. Kuhn, Jens H., John Misasi John, Peter Jahrling, and James Lawler. 2013. Marburgviruses and
125. Ebolaviruses. In Southwick, Frederick S., Bernard Hirschel, Adolf W. Karchmer, Carol A. Kauffman, and
126. Richard P. Wenzel (eds.). CDS:ID [Clinical Decision Support: Infectious Diseases]. Decision Support in
127. Medicine, LLC. Wilmington, Delaware, USA. https://www.decisionsupportinmedicine.com [Epub, June 2,
128. 2013].
129. 54. Mudhasani, Rajini, Julie P. Tran, Cary Retterer, Sheli R. Radoshitzky, Krishna Kota, Louis A. Altamura,
130. Jeffrey M. Smith, Beverly Z. Packard, Jens H. Kuhn, Julie Costantino, Aura R. Garrison, Connie S.
131. Schmaljohn, I-Chueh Huang, Michael Farzan, and Sina Bavari. 2013. IFITM-2 and IFITM-3 but Not IFITM-
132. 1 Restrict Rift Valley Fever. Journal of Virology (Washington, DC) 87(15): 8451-8464 [Epub May 29, 2013].
133. PMID: 23720721. PMCID:PMC3719792.
134. 55. Kuhn, Jens H., Sadia Bekal, Yíngyún Caì, Anna N. Clawson, Leslie L. Domier, Marieke Herrel, Peter B.
135. Jahrling, Hideki Kondo, Kris N. Lambert, Kathie A. Mihindukulasuriya, Norbert Nowotny, Sheli R.
136. Radoshitzky, Urs Schneider, Peter Staeheli, Nobuhiro Suzuki, Robert B. Tesh, David Wang, Lin-Fa Wang,
137. and Ralf G. Dietzgen. 2013. Nyamiviridae: Proposal for a new family in the order Mononegavirales. Archives of
138. Virology (Vienna) 158(10): 2209-2226 [Epub May 1, 2013]. PMID: 23636404. PMCID:PMC3857105.
139. 56. Kuhn, Jens H., Sheli R. Radoshitzky, Sina Bavari, and Peter B. Jahrling. 2013. The International Code of
140. Virus Classification and Nomenclature (ICVCN): proposal for text changes for improved differentiation of viral
141. taxa and viruses. Archives of Virology (Vienna) 158(7): 1621-1629 [Epub Feb. 16, 2013]. PMID: 23417351.
142. PMCID:PMC3689849.
143. 57. Kuhn, Jens H., Yiming Bao, Sina Bavari, Stephan Becker, Steven Bradfute, J. Rodney Brister, Alexander
144. A. Bukreyev, Yíngyún Caì, Kartik Chandran, Robert A. Davey, Olga Dolnik, John M. Dye, Sven
145. Enterlein, Jean-Paul Gonzalez, Pierre Formenty, Alexander N. Freiberg, Lisa Hensley, Anna N. Honko,
146. Georgy M. Ignatyev, Peter B. Jahrling, Karl M. Johnson, Hans-Dieter Klenk, Gary Kobinger, Matthew G.
147. Lackemeyer, Eric M. Leroy, Mark S. Lever, Loreen L. Lofts, Elke Mühlberger, Sergey V. Netesov, Gene
148. G. Olinger, Gustavo Palacios, Jean L. Patterson, Janusz T. Paweska, Louise Pitt, Sheli R. Radoshitzky,
149. Elena I. Ryabchikova, Erica Ollmann Saphire, Alexander M. Shestopalov, Sophie J. Smither, Nancy
150. Sullivan, Robert Swanepoel, Ayato Takada, Jonathan S. Towner, Guido van der Groen, Viktor E.
151. Volchkov, Victoria Wahl-Jensen, Travis K. Warren, Kelly L. Warfield, Manfred Weidmann, and Stuart T.
152. Nichol. 2013. Virus nomenclature below the species level: a standardized nomenclature for laboratory animaladapted
153. variants of viruses assigned to the family Filoviridae. Archives of Virology (Vienna) 158(6): 1425-1432
154. [Epub Jan. 29, 2013]. PMID: 23358612. PMCID: PMC3669655.
155. 58. Kuhn, Jens H., Yiming Bao, Sina Bavari, Stephan Becker, Steven Bradfute, J. Rodney Brister, Alexander
156. A. Bukreyev, Kartik Chandran, Robert A. Davey, Olga Dolnik, John M. Dye, Sven Enterlein, Lisa
157. Hensley, Anna N. Honko, Peter B. Jahrling, Karl M. Johnson, Gary Kobinger, Eric M. Leroy, Mark S.
158. Lever, Elke Mühlberger, Sergey V. Netesov, Gene G. Olinger, Gustavo Palacios, Jean L. Patterson, Janusz
159. T. Paweska, Louise Pitt, Sheli R. Radoshitzky, Erica Ollmann Saphire, Sophie J. Smither, Robert
160. Swanepoel, Jonathan S. Towner, Guido van der Groen, Viktor E. Volchkov, Victoria Wahl-Jensen, Travis
161. K. Warren, Manfred Weidmann, and Stuart T. Nichol. 2013. Virus nomenclature below the species level: a
162. standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Archives of
163. Virology (Vienna) 158(1): 301-311. [Epub September 23, 2012]. PMID: 23001720. PMCID:PMC3535543.
164. 59. Kuhn, Jens H., Sheli R. Radoshitzky, Sina Bavari, and Peter B. Jahrling. 2013. The International Code of
165. Virus Classification and Nomenclature (ICVCN): proposal to delete Rule 3.41. Archives of Virology (Vienna)
166. 158(1): 297-299 [Epub August 31, 2012]. PMID: 22932924. PMCID:PMC3541449.
167. 60. Lauck, Michael, Samuel Sibley, David Hyeroba, Alex Tumukunde, Geoffrey Weny, Colin A. Chapman,
168. Nelson Ting, William M. Switzer, Jens H. Kuhn, Thomas C. Friedrich, David H. O’Connor, and Tony L.
169. Goldberg. 2013. Exceptional Simian Hemorrhagic Fever Virus Diversity in a Wild African Primate Community.
170. Journal of Virology (Washington, DC) 87(1): 688-691 [Epub October 17, 2012]. PMID: 23077302.
171. PMCID:PMC3536393.
172. 61. Kugelman, Jeffrey R., Michael S. Lee, Cynthia A. Rossi, Sarah E. McCarthy, Sheli R. Radoshitzky, John
173. M. Dye, Lisa E. Hensley, Anna Honko, Jens H. Kuhn, Peter B. Jahrling, Travis K. Warren, Chris A.
174. Whitehouse, Sina Bavari, and Gustavo Palacios. 2012. Ebola Virus Genome Plasticity as a Marker of Its
175. Passaging History: A Comparison of In Vitro Passaging to Non-Human Primate Infection. PLoS ONE (San
176. Francisco) 7(11): e50316 [Epub November 28, 2012]. PMID: 23209706. PMCID: PMC3509072.
177. 62. Kuhn, Jens H.. 2012. Delete ICVCN Rule 3.41. ICTV [International Committee for Taxonomy of Viruses]
178. Proposal (Taxoprop) No. 2012.001aG.
179. http://talk.ictvonline.org/files/proposals/taxonomy_proposals_general1/default.aspx [Epub June 5, 2012]
180. 63. Radoshitzky, Sheli R., Jens H. Kuhn, Fabian de Kok-Mercado, Peter B. Jahrling, and Sina Bavari. 2012.
181. Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses. Expert
182. Opinion on Drug Discovery (London) 7(7): 613-632 [Epub May 19, 2012]. PMID: 22607481. PMCID:
183. PMC3426302.
184. 64. Bukreyev, Alexander A., Kartik Chandran, Olga Dolnik, John M. Dye, Hideki Ebihara, Jens H. Kuhn,
185. Eric Leroy, W. Ian Lipkin, Elke Mühlberger, Ana I. Negredo, Sergey V. Netesov, Gustavo Palacios, Jean
186. L. Patterson, Janusz T. Paweska, Erica Ollmann Saphire, Sophie J. Smither, Ayato Takada, Antonio
187. Tenorio, Jonathan Towner, Viktor E. Volchkov, and Travis K. Warren. 2012. Create Genus Cuevavirus in
188. the family Filoviridae. ICTV [International Committee for Taxonomy of Viruses] Proposal (Taxoprop) No.
189. 2012.005adV.
190. http://talk.ictvonline.org/files/proposals/taxonomy_proposals_vertebrate1/default.aspx [Epub June 8, 2012]
191. 65. Wahl-Jensen, Victoria, Sheli R. Radoshitzky, Sina Bavari, Peter B. Jahrling, and Jens H. Kuhn. 2012.
192. Practical Guidelines - Filoviruses: Hemorrhagic Fevers, pp. 344-349 (part B, chapter 13). In Elschner, Mandy,
193. Sally Cutler, Manfred Weidman, and Patrick Butaye (eds.). BSL3 and BSL4 Agents – Epidemiology,
194. Microbiology, and Practical Guidelines. Wiley-Blackwell, Weinheim, Baden-Württemberg, Germany.
195. 66. Shurtleff, Amy C., Steven B. Bradfute, Sheli R. Radoshitzky, Peter B. Jahrling, Jens H. Kuhn, and Sina
196. Bavari. 2012. Practical Guidelines - Arenaviruses: Hemorrhagic Fevers, pp. 338-343 (part B, chapter 12). In
197. Elschner, Mandy, Sally Cutler, Manfred Weidman, and Patrick Butaye (eds.). BSL3 and BSL4 Agents –
198. Epidemiology, Microbiology, and Practical Guidelines. Wiley-Blackwell, Weinheim, Baden-Württemberg,
199. Germany.
200. 67. Wahl-Jensen, Victoria, Sheli R. Radoshitzky, Sina Bavari, Peter B. Jahrling, and Jens H. Kuhn. 2012.
201. Pathogens - Filoviruses: Hemorrhagic Fevers, pp. 237-252 (part A, chapter 13). In Elschner, Mandy, Sally Cutler,
202. Manfred Weidman, and Patrick Butaye (eds.). BSL3 and BSL4 Agents – Epidemiology, Microbiology, and
203. Practical Guidelines. Wiley-Blackwell, Weinheim, Baden-Württemberg, Germany.
204. 68. Shurtleff, Amy C., Steven B. Bradfute, Sheli R. Radoshitzky, Peter B. Jahrling, Jens H. Kuhn, and Sina
205. Bavari. 2012. Pathogens - Arenaviruses: Hemorrhagic Fevers, pp. 211-235 (part A, chapter 12). In Elschner,
206. Mandy, Sally Cutler, Manfred Weidman, and Patrick Butaye (eds.). BSL3 and BSL4 Agents – Epidemiology,
207. Microbiology, and Practical Guidelines. Wiley-Blackwell, Weinheim, Baden-Württemberg, Germany.
208. 69. Kuhn, J. H., T. Ulrichs, and G.-D. Burchard. 2012. In German: Biologische Waffen – eine Herausforderung
209. an Diagnostik, Therapie, Klinik und Prävention [Biological weapons – a new challenge for diagnostics, therapy,
210. clinics and prevention], pp. 895-897 (chapter 127). In Suerbaum, Sebastian, Helmut Hahn, Gerd-Dieter Burchard,
211. Stefan H. E. Kaufmann, and Thomas F. Schulz (eds.). Medizinische Mikrobiologie und Infektiologie [Medical
212. microbiology and infectiology], 7th Edition. Springer-Verlag, Berlin, Germany [German].
213. 70. Ou, Wu, Josie Delisle, Jerome Jacques, Joanna Shih, Graeme Price, Jens H. Kuhn, Vivian Wang, Daniela
214. Verthelyi, Gerardo Kaplan, and Carolyn A. Wilson. 2012. Induction of ebolavirus cross-species immunity
215. using retrovirus-like particles bearing the Ebola Virus glycoprotein lacking the mucin-like domain. Virology
216. Journal (London) 9:32 [Epub January 25, 2012]. PMID:22273269. PMCID: PMC3284443.
217. 71. Kuhn Jens H., and John P. Woodall. 2012. Ebola and Marburg Virus Disease. In Wertheim, Heiman F. L.,
218. Peter Horby, and John P. Woodall (eds.). Atlas of Human Infectious Diseases. Wiley-Blackwell Publishing,
219. Hoboken, New Jersey, USA. [Online.] www.infectionatlas.com [10/24/2014, last accessed.]
220. 72. Kuhn, Jens H., Lori Dodd, Victoria Wahl-Jensen, Sheli R. Radoshitzky, Sina Bavari, and Peter Jahrling.
221. 2011. EVALUATION OF PERCEIVED THREAT DIFFERENCES POSED BY FILOVIRUS VARIANTS.
222. Biosecurity and Bioterrorism - Biodefense Strategy, Practice, and Science (Larchmont) 9(4): 361-371 [Epub
223. November 9, 2011]. PMID: 22070137. PMCID: PMC3233913.
224. 73. Kuhn, J. H., S. Becker, H. Ebihara, T. W. Geisbert, P. B. Jahrling, Y. Kawaoka, S. V. Netesov, S. T.
225. Nichol, C. J. Peters, V. E. Volchkov, and T. G. Ksiazek (the ICTV Filoviridae Study Group). 2011.
226. FAMILY FILOVIRIDAE, pp 665-671. In King, Andrew M. Q., Michael J. Adams, Eric B. Carstens, and Elliot J.
227. Lefkowitz (eds.). Virus Taxonomy - Ninth Report of the International Committee on Taxonomy of Viruses.
228. Elsevier/Academic Press, San Diego, California, USA.
229. 74. Wahl-Jensen, Victoria, Sabine Kurz, Friedericke Feldmann, Lukas K. Buehler, Jason Kindrachuk, Victor
230. DeFilippis, Jean da Silva Correia, Klaus Früh, Jens H. Kuhn, Dennis R. Burton, and Heinz Feldmann.
231. 2011. Ebola Virion Attachment and Entry into Human Macrophages Profoundly Effects Early Cellular Gene
232. Expression. PLoS Neglected Tropical Diseases (San Francisco) 5(10): e1359 [Epub October 19, 2011]. PMID:
233. 22028943. PMCID: PMC3196478.
234. 75. Johnson, Reed, Yingyun Cai, Victoria Wahl-Jensen, Ying Fang, Thomas Friedrich, Sheli R. Radoshitzky,
235. Krishna Kota, David O’Connor, Sina Bavari, Peter B. Jahrling, Tony Goldberg, and Jens H. Kuhn. 2011.
236. SIMIAN HEMORRHAGIC FEVER VIRUS AS A MODEL FOR RISK GROUP 4 PATHOGENS, pp. 227-232.
237. In «ФУНДАМЕНТАЛЬНЫЕ И ПРИКЛАДНЫЕ АСПЕКТЫ МЕДИЦИНСКОЙ ПРИМАТОЛОГИИ» -
238. Материалы второй международной научной конференции ["Fundamental'nye i prikladnye aspekty
239. medicinskoj primatologii" - Materialy vtoroj meždunarodnoj naučnoj konferencii/Proceedings of the 2nd
240. international conference “Fundamental and applied aspects of medical primatology”], vol. 1, August 8-10, Sochi-
241. Adler, Krasnodar Krai, Russia.
242. Jens H. Kuhn CV
243. 18
244. 76. Sheli R. Radoshitzky, Kelly L. Warfield, Xiaoli Chi, Lian Dong, Krishna Kota, Steven B. Bradfute,
245. Jacqueline D. Gearhart, Cary Retterer, Philip J. Kranzusch, John N. Misasi, Marc A. Hogenbirk, Victoria
246. Wahl-Jensen, Viktor E. Volchkov, James M. Cunningham, Peter B. Jahrling, M. Javad Aman, Sina
247. Bavari, Michael Farzan, and Jens H. Kuhn. 2011. Ebolavirus Δ-Peptide Immunoadhesins Inhibit
248. Marburgvirus and Ebolavirus Cell Entry. Journal of Virology (Washington, DC) 85(17): 8502-8513 [Epub June
249. 22, 2011]. PMID: 21697477. PMCID: PMC3165852. Chosen as an Article of Significant Interest by the Journal
250. of Virology Editorial Board.
251. 77. Radoshitzky, Sheli R., Lindsay E. Longobardi, Jens H. Kuhn, Cary Retterer, Lian Dong, Jeremiah C.
252. Clester, Krishna Kota, John Carra, and Sina Bavari. 2011. Machupo Virus Glycoprotein Determinants for
253. Human Transferrin Receptor 1 Binding and Cell Entry. PLoS ONE (San Francisco) 6(7): e21398 [Epub July 7,
254. 2011]. PMID: 21750710. PMCID: PMC3131282.
255. 78. Hoenen, Thomas, Allison Groseth, Fabian de Kok-Mercado, Jens H. Kuhn, and Victoria Wahl-Jensen.
256. 2011. Minigenomes, transcription and replication competent virus-like particles and beyond: Reverse genetics
257. systems for filoviruses and other negative stranded hemorrhagic fever viruses. Antiviral Research (Amsterdam)
258. 92(2): 195-208. PMID: 21699921 [Epub June 14, 2011].
259. 79. Ou, Wu, Josie Delisle, Krishnamurthy Konduru, Steven Bradfute, Sheli R. Radoshitzky, Cary Retterer,
260. Krishna Kota, Sina Bavari, Jens H. Kuhn, Peter B. Jahrling, Gerardo Kaplan, and Carolyn A. Wilson.
261. 2011. Development and characterization of rabbit and mouse antibodies against ebolavirus envelope
262. glycoproteins. Journal of Virological Methods (Amsterdam) 174(1-2): 99-109 [Epub April 13, 2011]. PMID:
263. 21513741. PMCID: PMC3106979.
264. 80. Kuhn, Jens H., Sheli R. Radoshitzky, and Peter B. Jahrling. 2011. PATHOGENS CAUSING VIRAL
265. HEMORRHAGIC FEVERS, pp. 489-498. In Katz, Rebecca, and Raymond A. Zilinskas (eds.).
266. ENCYCLOPEDIA OF BIOTERRORISM DEFENSE, 2nd Edition. Wiley-Blackwell, Hoboken, New Jersey,
267. USA.
268. 81. Jahrling, Peter B., and Kuhn, Jens H. 2011. HUMAN POXVIRUSES, pp. 312-316. In Katz, Rebecca, and
269. Raymond A. Zilinskas (eds.). ENCYCLOPEDIA OF BIOTERRORISM DEFENSE, 2nd Edition. Wiley-
270. Blackwell, Hoboken, New Jersey, USA.
271. 82. Keshtkar-Jahromi, Maryam, Jens H. Kuhn, Iva Christova, Steven B. Bradfute, Peter B. Jahrling, and Sina
272. Bavari. 2011. Crimean-Congo hemorrhagic fever: Current and future prospects of vaccines and therapies.
273. Antiviral Research (Amsterdam) 90(2): 85-92 [Epub March 5, 2011]. PMID: 21362441.
274. 83. Miller, Emily Happy, Joseph S. Harrison, Sheli R. Radoshitzky, Chelsea D. Higgins, Xiaoli Chi, Lian
275. Dong, Jens H. Kuhn, Sina Bavari, Jonathan R. Lai, and Kartik Chandran. 2011. Inhibition of Ebola Virus
276. Entry by a C-Peptide Targeted to Endosomes. The Journal of Biological Chemistry (Baltimore) 286(18): 15854-
277. 15861 [Epub March 16, 2011]. PMID: 21454542. PMCID: PMC3091195.
278. 84. Wahl-Jensen, Victoria, C. J. Peters, Peter B. Jahrling, Heinz Feldmann, and Jens H. Kuhn. 2011. Filovirus
279. Infections, pp. 483-491, e198-e201 (chapter 73). In Guerrant Richard L., David H. Walker, and Peter F. Weller:
280. TROPICAL INFECTIOUS DISEASES - PRINCIPLES, PATHOGENS, & PRACTICE, 3rd edn.
281. Elsevier/SAUNDERS, Edinburgh, UK.
282. 85. Huang, I-Chueh, Charles C. Bailey, Jessica L. Weyer, Sheli R. Radoshitzky, Michelle M. Becker, Jessica J.
283. Chiang, Abraham L. Brass, Asim A. Ahmed, Xiaoli Chi, Lian Dong, Lindsay E. Longobardi, Dutch Boltz,
284. Jens H. Kuhn, Stephen J. Elledge, Sina Bavari, Mark R. Denison, Hyeryun Choe, and Michael Farzan.
285. 2011. Distinct Patterns of IFITM-Mediated Restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus.
286. PLoS Pathogens (San Francisco) 7(1):e1001258 [Epub January 6, 2011]. PMID: 21253575. PMCID:
287. PMC3017121
288. 86. Kuhn, Jens H., Victoria Wahl-Jensen, and Peter B. Jahrling. 2010. Influenza Virus A/H5N1: ATLAS of
289. Reproduction and Pathological Changes of Mice Visceral Organs (Вирус гриппа A/H5N1: Aтлас репродукции
290. и патологических изменений внутренних органов мышей). By G. G. Onishchenko, E. I. Ryabchikova, A. N.
291. Sergeev, and I. G. Drozdov (Г. Г. Онищенко, Е. И. Рябчикова, А. Н. Сергеев, И. Г. Дроздов). Applied
292. Biosafety – Journal of the American Biological Safety Association (Mundelein) 15(4): 197.
293. 87. Jens H. Kuhn, and Victoria Wahl-Jensen. 2010. Being obsessive-compulsive about terminology and
294. nomenclature is not a vice, but a virtue. Bionomina – International Journal of Biological Nomenclature &
295. Terminology (St. Lukes) 1(1): 11-14 [Epub Dec. 24, 2010].
296. http://www.mapress.com/bionomina/content/2010/f/bn00001p014.pdf
297. 88. Jens H. Kuhn, Stephan Becker, Hideki Ebihara, Thomas W. Geisbert, Karl M. Johnson, Yoshihiro
298. Kawaoka, W. Ian Lipkin, Ana I. Negredo, Sergey V. Netesov, Stuart T. Nichol, Gustavo Palacios, Clarence
299. J. Peters, Antonio Tenorio, Viktor E. Volchkov, and Peter B. Jahrling. 2010. Proposal for a Revised
300. Taxonomy of the Family Filoviridae: Classification, Names of Taxa and Viruses, and Virus Abbreviations.
301. Archives of Virology (Vienna) 155(12): 2083-2103 [Epub Oct 30, 2010]. PMID: 21046175. PMCID:
302. PMC3074192.
303. 89. van Regenmortel, Marc H. V., Donald S. Burke, Charles H. Calisher, Ralf G. Dietzgen, Claude M.
304. Fauquet, Said A. Ghabrial, Peter B. Jahrling, Karl M. Johnson, Michael R. Holbrook, Marian C.
305. Horzinek, Günther M. Keil, Jens H. Kuhn, Brian W. J. Mahy, Giovanni P. Martelli, Craig Pringle,
306. Edward P. Rybicki, Tim Skern, Robert B. Tesh, Victoria Wahl-Jensen, Peter J. Walker, and Scott C.
307. Weaver. 2010. A proposal to change existing virus species names to non-Latinized binomials. Archives of
308. Virology (Vienna) 155(11): 1909-1919. [Epub Oct. 16, 2010]. PMID: 20953644.
309. 90. van Regenmortel, Marc, Donald Burke, Charles Calisher, Ralf Dietzgen, Claude Fauquet, Ghabrial Said,
310. Peter Jahrling, Karl Johnson, Michael Holbrook, Marian Horzinek, Keil Guenther, Jens Kuhn, Brian
311. Mahy, Giovanni Martelli, Craig Pringle, Ed Rybicki, Tim Skern, Robert Tesh, Victoria Wahl-Jensen,
312. Peter Walker, and Scott Weaver. 2010. Change existing virus species names to non-Latinized binomials. ICTV
313. [International Committee for Taxonomy of Viruses] Proposal (Taxoprop) No. 2011.001aG.
314. http://talk.ictvonline.org/files/proposals/taxonomy_proposals_general1/m/gen01/2518.aspx [Epub Aug. 5, 2010]
315. 91. Kuhn, Jens H., Stephan Becker, Hideki Ebihara, Thomas W. Geisbert, Karl M. Johnson, Yoshihiro
316. Kawaoka, Sergey V. Netesov, Stuart T. Nichol, Clarence J. Peters, Viktor E. Volchkov, and Peter B.
317. Jahrling. 2010. 1 new species in the genus Ebolavirus, family Filoviridae, and renaming of 1 species in the genus
318. Marburgvirus and 1 species in the genus Ebolavirus. ICTV [International Committee for Taxonomy of Viruses]
319. Proposal (Taxoprop) No. 2010.010.abV.
320. http://talk.ictvonline.org/files/proposals/taxonomy_proposals_vertebrate1/m/vert01/2282.aspx [Epub June 15,
321. 2010]
322. 92. Kuhn, Jens H., Peter B. Jahrling, and Sheli R. Radoshitzky. 2010. Viral Hemorrhagic Fevers, pp. 328-343
323. (chapter 20). In Jerome Keith A. (ed.), Lennette’s Laboratory Diagnosis of Viral Infections, 4th ed. Informa
324. HealthCare, New York, New York, USA.
325. 93. Kuhn, Jens H., and Peter B. Jahrling. 2010. Clarification and Guidance on the Proper Usage of Virus and
326. Virus Species Names. Archives of Virology (Vienna) 155(4):445-453 [Epub April 4, 2010]. PMID: 20204430.
327. PMCID: PMC2878132.
328. 94. Sheli R. Radoshitzky, Lian Dong, Xiaoli Chi, Jeremiah C. Clester, Cary Retterer, Kevin Spurgers, Jens H.
329. Kuhn, Sarah Sandwick, Gordon Ruthel, Krishna Kota, Dutch Boltz, Travis Warren, Philip J. Kranzusch,
330. Sean P. J. Whelan, and Sina Bavari. 2010. Infectious Lassa Virus, But Not Filoviruses, Is Restricted by
331. BST2/Tetherin. Journal of Virology (Washington, DC) 84(20): 10569-10580 [Epub August 4, 2010]. PMID:
332. 20686043. PMCID: PMC2950602.
333. 95. Kuhn, J. H., and T. Ulrichs. 2009. In German: Biologische Waffen – eine Herausforderung an Diagnostik,
334. Therapie, Klinik und Prävention [Biological weapons – a new challenge for diagnostics, therapy, clinics and
335. prevention], pp. 861-863 (chapter 129). In Hahn, Helmut, Stefan H. E. Kaufmann, Thomas F. Schulz, and
336. Sebastian Suerbaum (eds.). Medizinische Mikrobiologie und Infektiologie [Medical microbiology and
337. infectiology], 6th Edition. Springer Medizin Verlag, Heidelberg, Baden-Württemberg, Germany.
338. 96. Dube, Derek, Matthew B. Brecher, Sue E. Delos, Sean C. Rose, Edward W. Park, Kathryn L. Schornberg,
339. Jens H. Kuhn, and Judith M. White. 2009. The Primed Ebolavirus Glycoprotein (19-Kilodalton GP1,2):
340. Sequence and Residues Critical for Host Cell Binding. Journal of Virology (Washington, DC) 83(7): 2883-2891
341. [Epub January 14, 2009]. PMID: 19144707. PMCID: PMC2655554.
342. 97. Kuhn, Jens H. 2008. Crimean-Congo Hemorrhagic Fever – A Global Perspective. Edited by Onder Ergonul and
343. Chris A. Whitehouse. Applied Biosafety – Journal of the American Biological Safety Association (Mundelein)
344. 13(3): 175-176.
345. 98. Radoshitzky, Sheli R., Jens H. Kuhn, Christina F. Spiropoulou, César G. Albariño, Dan P. Nguyen, Jorge
346. Salazar-Bravo, Tatyana Dorfman, Amy S. Lee, Enxiu Wang, Susan R. Ross, Hyeryun Choe, and Michael
347. Farzan. 2008. Receptor determinants of zoonotic transmission of New World hemorrhagic fever arenaviruses.
348. PNAS – Proceedings of the National Academy of Sciences of the United States of America (Washington, DC)
349. 105(7):2664-2669 [Epub February 11, 2008]. PMID: 18268337. PMCID: PMC2268193
350. 99. Kuhn, Jens H. 2008. Emerging Viruses in Human Populations – Perspectives in Medical Virology (Vol. 16).
351. Edited by Edward Tabor. Applied Biosafety – Journal of the American Biological Safety Association
352. (Mundelein) 13(2):113-114.
353. 100. Sobolev, Alexander, Konstantin Severinov, Mikhail Kovalchuk, Mikhail Feigel'man, Rebecca Frumkina,
354. Jens Kuhn, Roald Sagdeev, Simon Lyakhovich, and Evgeny Antipov. 2007. Russian science: What the
355. scientists say. Nature (London) 449(7162):529-530. PMID: 17968378.
356. 101. Kuhn, Jens H., Wenhui Li, Sheli R. Radoshitzky, Hyeryun Choe, and Michael Farzan. 2007. Severe acute
357. respiratory coronavirus entry as a target of antiviral therapies. Antiviral Therapy (London) 12(4 Pt. B): 639-650.
358. PMID: 17944271.
359. 102. Li, Wenhui, Jianhua Sui, I-Chueh Huang, Jens H. Kuhn, Sheli R. Radoshitzky, Wayne A. Marasco,
360. Hyeryun Choe, and Michael Farzan. 2007. The S proteins of human coronavirus NL63 and severe acute
361. respiratory syndrome coronavirus bind overlapping regions of ACE2. Virology (New York) 367(2):367-374
362. [Epub July 12, 2007]. PMID: 17631932. PMCID: PMC2693060.
363. 103. Kuhn, Jens. 2007. BULLETIN briefing – What is biosecurity? – PREVENTION PROTOCOL. Bulletin of the
364. Atomic Scientists (Chicago) 63(2):18.
365. 104. Radoshitzky, Sheli R., Jonathan Abraham, Christina F. Spiropoulou, Jens H. Kuhn, Dan Nguyen,
366. Wenhui Li, Jane Nagel, Paul J. Schmidt, Jack H. Nunberg, Nancy C. Andrews, Michael Farzan, and
367. Hyeryun Choe. 2007. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever
368. arenaviruses. Nature (London) 446(7131):92-96 [Epub February 7, 2007]. PMID: 17287727. PMCID:
369. PMC3197705.
370. 105. Kuhn, J. H. 2006. In German: Moderne biologische Waffen – Bedrohungsszenarien und
371. Eindämmungsstrategien [Modern biological weapons – threat scenarios and prevention strategies], pp. 251-263.
372. In Janata, Oskar, and Emil C. Reisinger (eds.), Infektiologie – Aktuelle Aspekte. Jahrbuch 2006 [Infectiology –
373. current aspects. Annual proceedings 2006]. ÖVG - Österreichische Verlagsgesellschaft, Vienna, Austria.
374. 106. Kuhn, Jens H. 2006. Viral Haemorrhagic Fevers – Perspectives in Medical Virology (Volume 11) by Colin R.
375. Howard. Applied Biosafety – Journal of the American Biological Safety Association (Mundelein) 11(2): 98-99.
376. 107. Musella, Mario, Stefano de Franciscis, Andrea Amorosi, Francesco Milone, Simona Truvolo, Alfredo
377. Pede, and Jens K. [sic] Kuhn. 2006. CASTLE tumours of the thyroid – Value of multiplanar imaging
378. acquisition. With Italian abstract. Annali Italiani di Chirurgia (Bologna) 77(6):509-512. PMID: 17343235.
379. 108. Kuhn, Jens H. 2006. Deadly Cultures: Biological Weapons since 1945 edited by Mark Wheelis, Lajos Rózsa,
380. and Malcolm Dando. Nature (London) 439(7075):393-394.
381. Reprinted in The ASA Newsletter (Aberdeen) (113):20-21 (2006).
382. 109. Li, Wenhui, Swee-Kee Wong, Fang Li, Jens H. Kuhn, I-Chueh Huang, Hyeryun Choe, and Michael
383. Farzan. 2006. Animal Origins of the Severe Acute Respiratory Syndrome Coronavirus: Insight from ACE2-SProtein
384. Interactions. Journal of Virology (Washington, DC) 80(9): 4211-4219. PMID: 16611880. PMCID:
385. PMC1472041.
386. 110. Kuhn, J. H., S. R. Radoshitzky, W. Li, S. Kee Wong, H. Choe, and M. Farzan. 2006. THE SARS
387. CORONAVIRUS RECEPTOR ACE2 – A POTENTIAL TARGET FOR ANTIVIRAL THERAPY, pp. 397-418
388. (chapter 3.1). In Bogner, Elke, and Andreas Holzenburg (eds.), New Concepts of Antiviral Therapy, Springer,
389. Dordrecht, The Netherlands.
390. 111. Kuhn, Jens H., Sheli R. Radoshitzky, Alexander C. Guth, Kelly L. Warfield, Wenhui Li, Martin J.
391. Vincent, Jonathan S. Towner, Stuart T. Nichol, Sina Bavari, Hyeryun Choe, M. Javad Aman, and Michael
392. Farzan. 2006. Conserved Receptor-binding Domains of Lake Victoria Marburgvirus and Zaire Ebolavirus Bind a
393. Common Receptor. The Journal of Biological Chemistry (Baltimore) 281(23):15951-15959 [Epub April 4,
394. 2006]. PMID: 16595665.
395. 112. Kuhn, Jens H. 2006. In German: Filoviren [Filoviruses], pp. 355-359 (chapter 3/2.2.10). In Mittermayer,
396. Helmut, and Franz Allerberger (eds.), Spektrum der Infektionskrankheiten – Diagnostik, Verlauf und zeitgemäße
397. Therapie [Spectrum of infectious diseases – Diagnostics, course of disease, and contemporary therapy], vol. 1.
398. Spitta Verlag, Balingen, Baden-Württemberg, Germany.
399. 113. Kuhn, Jens H. 2006. In German: Arenaviren [Arenaviruses], pp. 350-355 (chapter 3/2.2.9). In Mittermayer,
400. Helmut, and Franz Allerberger (eds.), Spektrum der Infektionskrankheiten – Diagnostik, Verlauf und zeitgemäße
401. Therapie [Spectrum of infectious diseases – Diagnostics, course of disease, and contemporary therapy], vol. 1.
402. Spitta Verlag, Balingen, Baden-Württemberg, Germany.
403. 114. Kuhn, Jens H. 2006. In German: Bunyaviren [Bunyaviruses], pp. 345-350 (chapter 3/2.2.8). In Mittermayer,
404. Helmut, and Franz Allerberger (eds.), Spektrum der Infektionskrankheiten – Diagnostik, Verlauf und zeitgemäße
405. Therapie [Spectrum of infectious diseases – Diagnostics, course of disease, and contemporary therapy], vol. 1.
406. Spitta Verlag, Balingen, Baden-Württemberg, Germany.
407. 115. Li, Wenhui, Chengsheng Zhang, Jianhua Sui, Jens H. Kuhn, Michael J. Moore, Shiwen Luo, Swee-Kee
408. Wong, I-Chueh Huang, Keming Xu, Natalya Vasilieva, Akikazu Murakami, Yaqing He, Wayne A.
409. Marasco, Yi Guan, Hyeryun Choe, and Michael Farzan. 2005. Receptor and viral determinants of SARScoronavirus
410. adaptation to human ACE2. The EMBO Journal (Oxford) 24(8):1634-1643 [Epub March 24, 2005].
411. PMID: 15791205. PMCID: PMC1142572.
412. 116. Kuhn, Jens H., Milton Leitenberg, and Raymond A. Zilinskas. 2005. Biological Espionage: Special
413. Operations of the Soviet and Russian Foreign Intelligence Services in the West by Alexander Kouzminov. Nature
414. (London) 436(7051):628-629.
415. Reprinted in The ASA Newsletter (Aberdeen) (112):21-22 (2006).
416. 117. Онищенко, Г. Г., И. Ю. Туманова, О. И. Вышемирский, J. Kuhn, С. В. Серегин, Г. И. Тюнников, И.
417. Д. Петрова, Ф. Х. Тишкова, К. С. Оспанов, С. В. Казаков, С. К. Каримов, А. С. Есмагамбетова, С. В.
418. Нетесов и В. С. Петров [Oniŝenko G. G., Tumanova I. Û. , Vyšemirskij O. I., Kuhn J., Seregin S. V.,
419. Tûnnikov G. I., Petrova I. D., Tiškova F. H., Ospanov K. S., Kazakov S. V., Karimov S. K.,
420. Esmagambetova A. S., Netesov S. V. and Petrov V. S.]. 2005. In Russian: ИССЛЕДОВАНИЕ
421. ВИРУСОФОРНОСТИ ИКСОДОВЫХ КЛЕЩЕЙ В ОЧАГАХ КРЫМСКОЙ–КОНГО
422. ГЕМОРРАГИЧЕСКОЙ ЛИХОРАДКИ КАЗАХСТАНА И ТАДЖИКИСТАНА [Issledovanie virusofornosti
423. iksodovyh kleŝej v očagah Krymskoj–Kongo gemorragičeskoj lihoradki Kazahstana i Tadžikistana]. With
424. English abstract: STUDY OF VIRUS CONTAMINATION OF IXODES TICKS IN THE FOCI OF CRIMEANCONGO
425. HEMORRHAGIC FEVER IN KAZAKHSTAN AND TAJIKISTAN. Журнал Микробиологии,
426. Эпидемиологии и Иммунобиологии (Москва) [Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii
427. (Moskva)] (1):27-31. PMID: 15773396.
428. 118. Kuhn, Jens H. 2005. QUALITATIVE AND QUANTITATIVE ASSESSMENT OF THE “DANGEROUS
429. ACTIVITIES” CATEGORIES DEFINED BY THE CISSM CONTROLLING DANGEROUS PATHOGENS
430. PROJECT. Working paper prepared for John Steinbruner, Elisa D. Harris, Nancy Gallagher, Stacy Okutani, and
431. the Center for International and Security Studies at Maryland’s (CISSM’s) Project “Controlling Dangerous
432. Pathogens: A Prototype Protective Oversight System”. 500 pages. [Online.]
433. http://www.cissm.umd.edu/papers/display.php?id=531 [06/10/2011, last accessed.]
434. 119. Kuhn, Jens H. 2005. Ebola and Marburg Viruses – Molecular and Cellular Biology. Edited by Hans-Dieter
435. Klenk and Heinz Feldmann. Applied Biosafety – Journal of the American Biological Safety Association
436. (Mundelein) 10(1):57-58.
437. 120. Онищенко Г. Г., Туманова И. Ю., Вышемирский О. И., Kuhn Jens H., Серегин С. В., Тюнников Г.
438. И., Петрова И. Д., Тишкова Ф. Х., Оспанов К. С., Казаков С. В., Каримов С. К., Есмагамбетова А.
439. С., Нетесов С. В., Петров В. С. [Oniŝenko G. G., Tumanova I. Û. , Vyšemirskij O. I., Kuhn Jens H.,
440. Seregin S. V., Tûnnikov G. I., Petrova I. D., Tiškova F. H., Ospanov K. S., Kazakov S. V., Karimov S. K.,
441. Esmagambetova A. S., Netesov S. V. and Petrov V. S.]. 2005. In Russian: Исследования методами ИФА и
442. ОТ-ПЦР вирусофорности иксодовых клещей, собранных в очагах Крымской–Конго геморрагической
443. лихорадки Казахстана и Таджикистана в 2001-2002 гг. [Issledovaniâ metodami IFA i OT-PCR virusofornosti
444. iksodovyh kleŝej, sobrannyh v očagah Krymskoj–Kongo gemorragičeskoj lihoradki Kazahstana i Tadžikistana v
445. 2001-2002 gg.]. With English abstract: ELISA and RT-PCR-based research of viruses in the ticks collected in the
446. foci of Crimean-Congo fever in Kazakhstan and Tajikistan in 2001-2002. Вопросы Вирусологии (Москва)
447. [Voprosy Virusologii – Problems of Virology (Moskva)] 50(1):23-26. PMID: 15747867.
448. 121. Ulrichs, Timo, Jens Kuhn, and Helmut Hahn. 2005. In German: Mögliche Gefahren durch Bioterrorismus -
449. DIE BEDROHUNG DURCH VORSÄTZLICH FREIGESETZTE MIKROORGANISMEN UND ANDERER
450. AGENZIEN [Possible dangers stemming from bioterrorism - the threat of deliberately released microorganisms
451. and other agents]. fundiert (Berlin) (1):20-27. [Online.] http://www.elfenbeinturm.net/archiv/2005/02.html
452. [09/07/2009, last accessed.]
453. 122. Kuhn, Jens H. 2005. Filoviruses Reached the Soviet Union Via Normal Scientific Channels. Special News
454. Report, posted on March 15. Russian BW Monitor. [Online.] http://www.russianbwmonitor.com [site now
455. inactive]
456. 123. Kuhn, J. H., I. D. Petrova, S. V. Seregin, O. I. Vyshemirskii, D. K. Lvov, G. I. Tyunnikov, V. V. Gutorov,
457. L. N. Yashina, S. V. Netesov, and V. S. Petrov. 2004. Genetic analysis of the M RNA segment of Crimean-
458. Congo hemorrhagic fever virus strains involved in the recent outbreaks in Russia. Archives of Virology (Vienna)
459. 149(11):2199-2213 [Epub June 15, 2004]. PMID: 15503207
460. 124. Kuhn, Jens H. 2004. Emergence and Control of Zoonotic Viral Encephalitides – Edited by C. H. Calisher and
461. D. E. Griffin. Applied Biosafety – Journal of the American Biological Safety Association (Mundelein) 9(4):223-
462. 224.
463. 125. Moore, Michael J., Tatyana Dorfman, Wenhui Li, Swee Kee Wong, Yanhan Li, Jens H. Kuhn, James
464. Coderre, Natalya Vasilieva, Zhongchao Han, Thomas C. Greenough, Michael Farzan, and Hyeryun Choe.
465. 2004. Retroviruses Pseudotyped with the Severe Acute Respiratory Syndrome Coronavirus Spike Protein
466. Efficiently Infect Cells Expressing Angiotensin-Converting Enzyme 2. Journal of Virology (Washington, DC)
467. 78(19):10628-10635. PMID: 15367630. PMCID: PMC516384.
468. 126. Kuhn, Jens H. 2004. Ebola and Marburg Viruses: A View of Infection Using Electron Microscopy by E. I.
469. Ryabchikova and B. B. Price. Applied Biosafety – Journal of the American Biological Safety Association
470. (Mundelein) 9(1):37-38.
471. Partially reprinted in The ASA Newsletter (Aberdeen) (100):2 (2004).
472. 127. Kuhn, J. H., W. Li, H. Choe, and M. Farzan. 2004. Angiotensin-converting enzyme 2: a functional receptor
473. for SARS coronavirus. CMLS – Cellular and Molecular Life Sciences (Basel) 61(11):2738-2743. PMID:
474. 15549175.
475. 128. Kuhn, J. H., and T. Ulrichs. 2004. In German: Biologische Waffen – eine neue Herausforderung an
476. Diagnostik, Therapie, Klinik und Prävention [Biological weapons – a new challenge for diagnostics, therapy,
477. clinics and prevention], pp. 981-983 (chapter XVI-16). In Hahn, H., D. Falke, S. H. E. Kaufmann, and U.
478. Ullmann (eds.). Medizinische Mikrobiologie und Infektiologie [Medical microbiology and infectiology], 5th
479. Edition. Springer-Verlag, Berlin, Germany.
480. 129. Yashina, Lyudmila, Irina Petrova, Sergei Seregin, Oleg Vyshemirskii, Dmitrii Lvov, Valeriya Aristova,
481. Jens Kuhn, Sergey Morzunov, Valery Gutorov, Irina Kuzina, Georgii Tyunnikov, Sergei Netesov, and
482. Vladimir Petrov. 2003. Genetic variability of Crimean-Congo haemorrhagic fever virus in Russia and Central
483. Asia. The Journal of General Virology (London) 84(Pt. 5):1199-1206. PMID: 12692285.
484. 130. Kuhn, J. H. 2003. In German: Die expandierende Familie der Paramyxoviren – zoonotisches Potential
485. uncharakterisierter und neuer Mitglieder [The expanding family of paramyxoviruses – zoonotic potential of
486. uncharacterized and novel members], pp. 369-379. In Janata, Oskar, and Emil C. Reisinger (eds.), Jahrbuch
487. 2003/2004. Infektiologie – Aktuelle Aspekte [Annual proceedings 2003/2004. Infectiology – current aspects].
488. pm-Verlag, Korneuburg, Austria.
489. 131. Kuhn, J. H. 2003. In German: Die fortschreitende Integration eines ehemaligen sowjetischen B-Waffenlabors
490. in die internationale Forschungsgemeinschaft [The progressing integration of a former bioweapons laboratory
491. into the international research society], pp. 359-368, and 405-408. In Janata, Oskar, and Emil C. Reisinger (eds.),
492. Jahrbuch 2003/2004. Infektiologie – Aktuelle Aspekte [Annual proceedings 2003/2004. Infectiology – current
493. aspects]. pm-Verlag, Korneuburg, Austria.
494. 132. Kuhn, Jens. 2003. In German: Biologische Waffen – über die Schwierigkeiten ihrer Herstellung, die
495. Wahrscheinlichkeit ihrer Anwendung und Möglichkeiten sie zu kontrollieren [Biological weapons – on the
496. difficulties of their construction, the probability of their use, and possibilities to control them]. Zeitschrift für
497. Biopolitik (Berlin) 2(3):169-180.
498. Reprint: 2004. In Mietzsch, Andreas (ed.), KURSBUCH BIOPOLITIK – Höhepunkte der ZEITSCHRIFT
499. für BIOPOLITIK 2002/2003 [Course book biopolitics – Highlights of the Zeitschrift für Biopolitik],
500. BIOCOM AG, Berlin, Germany, pp. 147-161.
501. 133. di Palma, R., M. Bellini, G. Salvatore, P. Caiazzo, C. de Martino, J. H. Kuhn, and M. Musella. 2003.
502. Treatment of a spontaneously ruptured hepatic hemangioma with absorbable packing. With Italian abstract:
503. Trattamento di una rottura spontanea di emangioma epatico mediante packing riassorbibile. Chirurgia (Turin)
504. 16(2):77-79.
505. 134. Kuhn, Jens H. 2003. Collaborative Research on Crimean-Congo hemorrhagic fever virus at SRCVB “Vector”
506. – Scientific and Biosafety Aspects, pp. 165-178 (chapter 12). In Richmond, Jonathan Y. (ed.), Arthropod Borne
507. Diseases. Anthology of Biosafety, vol. VI. American Biological Safety Association, Mundelein, Illinois, USA.
508. 135. Kuhn, Jens. 2001. In German: „Natürlich bleiben Wunden“. Ein Bericht aus einst geheimen Labors in Sibrien
509. [“Wounds persist of course”. A report from former secret laboratories in Siberia]. DER SPIEGEL (Hamburg)
510. (50, Monday, 12/10/2001):232.
511. 136. Kuhn, Jens. 2001. In German: Biowaffen – Friedliche Perspektiven für ehemalige sowjetische
512. Biowaffenforscher [Bioweapons – Peaceful perspectives for former Soviet bioweapon researchers]. FAZ Online
513. – Frankfurter Allgemeine Zeitung Online (Berlin).
514. 137. Kuhn, Jens. 2001. In German: Biowaffen – Militärische Forschung friedlich umwandeln [Bioweapons –
515. Peaceful conversion of military research]. FAZ Online – Frankfurter Allgemeine Zeitung Online (Berlin).
516. 138. Farzan, Michael, Christine E. Schnitzler, Natalya Vasilieva, Doris Leung, Jens Kuhn, Craig Gerard,
517. Norma P. Gerard, and Hyeryun Choe. 2001. Sulfated Tyrosines Contribute to the Formation of the C5a
518. Docking Site of the Human C5a Anaphylatoxin Receptor. The Journal of Experimental Medicine (New York)
519. 193(9):1059-1066. PMID: 11342590. PMCID: PMC2193433.
520. 139. Kuhn, J. H. 2001. In German: Filoviren als biologische Waffen – Bedrohung, Fakt oder Fiktion? [Filoviruses
521. as biological weapons – threat, fact, or fiction?], pp. 299-307. In Janata, Oskar, and Emil C. Reisinger (eds.),
522. Jahrbuch 2001/2002. Infektiologie – Aktuelle Aspekte, vol. 3. Österreichische Gesellschaft für
523. Infektionskrankheiten [Annual proceedings 2001/2002. Infectiology – current aspects. Austrian society of
524. infectious diseases]. Springer-Verlag, Vienna, Austria.
525. 140. Kuhn, J. H. 2001. In German: Hämorrhagische Fieber aufgrund von Marburg- und Ebola-Viren [Hemorrhagic
526. fevers due to Marburg and Ebola viruses], pp. 309-321. In Janata, Oskar, and Emil C. Reisinger (eds.), Jahrbuch
527. 2001/2002. Infektiologie – Aktuelle Aspekte, vol. 3. Österreichische Gesellschaft für Infektionskrankheiten
528. [Annual proceedings 2001/2002. Infectiology – current aspects. Austrian society of infectious diseases].
529. Springer-Verlag, Vienna, Austria.
530. 141. Farzan, Michael, Hyeryun Choe, Elizabeth Desjardins, Ying Sun, Jens Kuhn, Jie Cao, Danielle
531. Archambault, Peter Kolchinsky, Markus Koch, Richard Wyatt, and Joseph Sodroski. 1998. Stabilization of
532. Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trimers by Disulfide Bonds Introduced into the
533. gp41 Glycoprotein Ectodomain. Journal of Virology (Washington, DC) 72(9):7620-7625. PMID: 9696864.
534. PMCID: PMC110020.

Working Papers:

Conference abstracts:

Posters:

Acknowledgments:

1. National Research Council. 2014. Science Needs for Microbial Forensics: Initial International Research Priorities. The National Academies Press, Washington, DC, USA.
2. Quammen, David. 2012. Spillover: Animal Infections and the Next Human Pandemic. W. W. Norton & Company, New York, New York, USA.
3. Colwell, Rita R., Enriqueta C. Bond, John D. Clements, Nancy D. Connell, Clarissa Dirks, Mohamed el-Faham, Elizabeth Heitman, Adel A. F. Mahmoud, and James H. Stith (the Committee). 2012. Research in the Life Sciences with Dual Use Potential – An International Faculty Development Project on Education About the Responsible Conduct in Science. Board on Life Sciences, Division on Earth and Life Studies, The National Academies of Sciences (NAS), Washington, DC, USA.
4. Postler, Thomas S., José M. Martinez-Navio, Eloísa Yuste, and Ronald C. Desrosiers. 2011. Evidence against Extracellular Exposure of a Highly Immunogenic Region in the C-Terminal Domain of the Simian Immunodeficiency Virus gp41 Transmembrane Protein. Journal of Virology (Washington, DC) 86(2):1145-57 [Epub November 9, 2011]. PMID: 22072749. PMCID: PMC3255797.
5. Bradfute, Steven B., John M. Dye, Jr., and Sina Bavari. 2011. Filovirus vaccines. Human Vaccines (Georgetown) 7(6):701-711 [Epub June 1, 2011]. PMID: 21519188.
6. Lofts, Loreen L., Jay B. Wells, Sina Bavari, and Kelly L. Warfield. 2011. Key genomic Changes Necessary for an In Vivo Lethal Mouse Marburgvirus Variant Selection Process. Journal of Virology (Washington, DC) 85(8):3905-3917 [Epub February 2, 2011]. PMID: 21289122. PMCID: PMC3126133.
7. Spurgers, Kevin B., Tim Alefantis, Brian D. Peyser, Gordon T. Ruthel, Alison A. Bergeron, Julie A. Costantino, Sven Enterlein, Krishna P. Kota, R. C. Dutch Boltz, M. Javad Aman, Vito G DelVecchio, and Sina Bavari. 2010. Identification of essential filovirion-associated host factors by serial proteomic analysis and RNAi screen. MCP - Molecular & Cell Proteomics (Bethesda) 9(12):2690-2703 [Epub August 11, 2010]. PMID: 20702783. PMCID: PMC3101857.
8. Warren, Travis K., Kelly L. Warfield, Jay Wells, Dana L. Swenson, Kelly S. Donner, Sean A. van Tongeren, Nicole I. Garza, Lian Dong, Dan V. Mourich, Stacy Crumley, Donald K. Nichols, Patrick L. Iversen, and Sina Bavari. 2010. Advanced antisense therapies for postexposure protection against lethal filovirus infections. Nature Medicine (London) 16(9):991-994 [Epub August 22, 2010]. PMID: 20729866.
9. Postler, Thomas S., Murat T. Budak, Tejvir S. Khurana, and Neal A. Rubinstein. 2009. Influence of hyperthryroid conditions on gene expression in extraocular muscles of rats. Physiological Genomics (Bethesda) 37(3):231-238 [Epub March 10, 2009]. PMID: 19276241. PMCID: PMC2685502
10. Hewlett, Barry S., and Bonnie L. Hewlett. 2008. Ebola, Culture, and Politics – The Anthropology of an Emerging Disease. Case Studies on Contemporary Social Issues. Thomson Wadsworth, Belmont, California, USA.
11. Steinbruner, John, Elisa D. Harris, Nancy Gallagher, and Stacy M. Okutani. 2007. Controlling Dangerous Pathogens: A Prototype Protective Oversight System. Advanced Methods of Cooperative Security Program. [Online.] http://www.cissm.umd.edu/papers/files/pathogens_project_monograph.pdf [01/06/2013, last accessed.]
12. Hart, John. 2006. The Soviet Biological Weapons Program, pp. 132-156 (chapter 6). In Wheelis, Mark, Lajos Rózsa, and Malcolm Dando (eds.), Deadly Cultures: Biological Weapons since 1945. Harvard University Press, Cambridge, Massachusetts, USA.
13. Sokol, Daniel K. 2002. FROM ANONOMYTY TO NOTORIETY. HISTORICAL PROBLEMS ASSOCIATED WITH OUTBREAKS OF EMERGING INFECTIOUS DISEASES; A CASE STUDY: EBOLA HAEMORRHAGIC FEVER. Thesis for the degree of Master of Science in Social and Economic History. University of Oxford, Oxford, United Kingdom. [Online.] www.medicalethicist.net [09/07/2009, last accessed.]
14. Hahn, H., D. Falke, S. H. E. Kaufmann, and U. Ullmann (eds.). 2001. In German: Medizinische Mikrobiologie und Infektiologie [Medical microbiology and infectiology], 4th Edition. Springer-Verlag, Berlin, Germany.

Panels/Roundtables:

1. 2007-2008: Online Roundtable between Gigi Kwik Gronvall, Jens Kuhn, Iris Hunger, and Leonid F. Ryabikhin: Is the availability of genetic information dangerous? 1st posted commentary (Nov. 13, 2007): Questions to consider about gene synthesis technology; 2nd posted commentary (Dec. 18, 2007): Defining the terrorist risk; 3rd posted commentary (Jan. 18, 2008): Stopping dangerous research before it starts; and 4th posted commentary (Feb. 15, 2008): The biosecurity risks not yet addressed. Bulletin of the Atomic Scientists (Chicago) [Online.] http://www.thebulletin.org/web-edition/roundtables/is-the-availability-genetic-informationdangerous [09/07/2009, last accessed.]
2. 2006: Massachusetts Institute of Technology Synthetic Biology Working Group Town Hall Meeting, April 21, MIT Stata Center, Cambridge, Massachusetts, USA.
3. 2005: Workshop on Protective Oversight of Dual-Use Research, October 21. American Academy of Arts and Sciences, and Center for International and Security Studies at Maryland (CISSM), Cambridge, Massachusetts,

4. 2004: Controlling Dangerous Pathogens Project. Workshop on Defining Dangerous Research, May 17 (junior scientist workshop) and May 18 (senior scientist workshop). Organized and hosted by the Center for International and Security Studies at Maryland (CISSM), The University of Maryland University College Inn and Conference Center, College Park, Maryland, USA.
5. 2003: Panel discussion ZEIT-Forum der Wissenschaft „Bioterrorismus: Die unsichtbare Bedrohung” [ZEIT forum of science “Bioterrorism: the invisible threat”], April 3, Berlin-Brandenburgische Akademie der Wissenschaften [Berlin-Brandenburg Academy of Sciences], Berlin, Germany. Discussing guests: Prof. Dr. med. Dr. rer. nat. Alexander Kekulé (Head of the Institute of Medical Microbiology of Martin-Luther Universität Halle-Wittenberg, Germany); Jens Kuhn; Prof. Dr. Reinhardt Kurth (President of the Robert-Koch Institute in Berlin, Germany); Otto Schily (Minister of the Interior of Germany). Transmitted live by Deutschlandfunk [Radio Germany]. Live recording broadcasted by Phoenix TV (Bonn) on April 5. Newspaper reprint of parts of the discussion: Die Zeit (Hamburg) 58(16, Thursday 04/10/2003):45. Different excerpts also to be found at [Online.] http://www.zeit.de/wissen/bioterror_forum [09/07/2009, last accessed.]

Press Interviews/Commentary Requests:

1. Interviewed on 01/20/2015 by William J. Broad, The New York Times (New York). Topic: The geographic distribution of filoviruses.
2. Interviewed on 08/28/2014 by Susannah Locke, Vox.com. Topic: Genomic analysis of Sierra Leonean Ebola virus isolates.
3. Interviewed on 08/27/2014 by Jennifer Yang, The Toronto (Canada) Star (Toronto). Topic: Genomic analysis of Sierra Leonean Ebola virus isolates. → See Yang, Jennifer. DNA sequences reveal Ebola's spread and mutations. http://www.thestar.com/news/world/2014/08/28/dna_sequences_reveal_ebolas_spread_and_mutations.html [08/28/2014, last accessed].
4. Interviewed on 08/17/2014 by Richard Preston, The New Yorker (New York). Topic: Ebolaviruses.
5. Interviewed on 05/02/2014 by Vincent R. Racaniello, Alan Dove, Rich Condit, and Kathy Spindler, This Week in Virology (TWiV) Podcast (New York). Published for download on iTunes and on http://www.twiv.tv/ on 05/04/2014: Episode TWiV 283 “No Reston for the weary” (110 min).
6. Interviewed on 04/16/2014 by Steve Baragona, Voice of America. Topic: The new “strain” of Ebola virus discovered in West Africa. → See Baragona, Steve. New Ebola Strain Causing West Africa Outbreak. http://www.voanews.com/content/new-ebola-strain-causing-west-africa-outbreak/1895149.html [04/17/2014, last accessed]. → Also broadcasted in full-length on radio.
7. Interviewed on 01/08/2013 by Elie Dolgin, Nature Medicine (New York): Topic: The FDA Animal Rule.
8. Interviewed on 11/10/2011 by Douglas Main, Discover Magazine (New York): Topic: Discovery of a novel filovirus, Lloviu virus, in Spain.
9. Interviewed on 03/30/2009 by Thomas Gabrielczyk, transkript (Berlin). Topic: Risks and benefits of new developments in synthetic biology. → See article: Gabrielczyk, Thomas. 2009. Biologie 2.0: Forschungs- Förderer beziehen Position [Biology 2.0: Science supporters take on a position]. transkript (Berlin) 15(7):33-34.
10. Interviewed on 01/17/2008 by Daniel Cressey, Nature (London). Topic: The creation of a “biologically contained Ebola virus.” → See article: Cressey, Daniel. 2008. ‘Safe’ form of Ebola created. NatureNews, published online on January 21, 2008, doi:10/1038/news.2008.519.
11. Interviewed on 09/19/2007 by Yudhijit Bhattacharjee, Science (Washington, DC). Topic: the National Academy Press Report “The Biological Threat Reduction Program of the Department of Defense: From Foreign Assistance to Sustainable Partnerships.”
12. Interviewed on 08/08/2007 by Daniel Cressey, Nature (London). Topic: Biosecurity and Biosafety of Containment Facilities in light of the accidental release of foot-and-mouth disease virus from such a facility in the UK. → See article: Cressey, Daniel. 2007. Not so secure after all. Nature (London) 448(7155):732-733.
13. Interviewed on 01/17/2007 by Margaret Munro, CanWest News Service. Topic: Nonhuman primate model for the simulation of Spanish influenza. → See article: Munro, Margaret. 2007.Recreation of killer flu sparks safety fears. Appeared in several CanWest-syndicated Canadian newspapers on 01/19/2007, among them the National Post.
14. Interviewed on 01/11/2007 by Kerri Smith, Nature (London). Topic: Nonhuman primate model for the simulation of Spanish influenza. → See article: Smith, Kerri. 2007. Concern as revived 1918 flu virus kills monkeys. Nature (London) 445(7125):237.
15. Interviewed on 10/20/2006 by Laura Allen, Popular Science (Tampa). Topic: Reconstruction of 1918 influenza A virus. → See article: Allen, Laura. 2007. IT CAME FROM THE LAB! Popular Science (Tampa) 270(2):59-63.
16. Interviewed on 10/12/2006 by Eric Lipton, The New York Times (New York). Topic: Changes of overall US research funding due to biodefense.
17. Interviewed on 09/20/2006 by Peter Aldhous, New Scientist (London). Topic: Oversight of dual-use research. → See article: Aldhous, Peter. 2006. Special Report Bioterror. FRIEND OR FOE? New Scientist (London) (2573):20-23.
18. Interviewed on 07/06/2006 by Douglas Birch, The Baltimore Sun (Baltimore). Topic: Alexander Kouzminov’s book “Biological Espionage.” → See article: Birch, Douglas. 2006. A spy among us? Soviet mole might have smuggled deadly viruses out of a Maryland army base in the 1980's, experts say. The Baltimore Sun (Baltimore) Sunday 07/30/2006:A1, and A12 (not quoted).
19. Interviewed on 04/13/2006 by Gareth Cook, The Boston Globe (Boston). Topic: are bats potential reservoirs of ebolaviruses? → See article: Cook, Gareth. 2006. The real bat-man story – True, bats carry deadly diseases, but it’s human beings who cause the outbreaks. The Boston Globe (Boston) Monday 04/24/2006:C1, and C4.
20. Interviewed on 11/23/2005 by Jamie Shreeve, New York Times Magazine (New York). Topic: reconstruction of the 1918 influenza virus. → See article: Shreeve, Jamie. 2006. Why Revive a Deadly Flu Virus?. The New York Times Magazine (New York) Sunday 01/29/2006. Topic: reconstruction of the 1918 H1N1 influenza virus (not quoted).
21. Interviewed on 11/08/2005 by Margaret Munro, CanWest News Service. Topic: the decision of the CDC to mail out plasmids containing reconstructed 1918 influenza virus. → See article: Munro, Margaret. 2005. Canadians to grow 1918 virus: Risk accidental release: Scientists hope to get insight into spread of flu. Appeared in several CanWest-syndicated Canadian newspapers.
22. Interviewed on 11/08/2005 by Jack Lucentini, World-Science.net. Topic: the decision of the CDC to mail out plasmids containing reconstructed 1918 influenza virus. → See article: Did U.S. government lie about deadly virus? [Online] http://www.world-science.net/othernews/051109_flufrm.htm [09/07/2009, last accessed; posted on 11/09/2005]
23. Interviewed on 11/06-07/2005 by Andreas von Bubnoff, Nature (London). Topic: reconstruction of the 1918 influenza virus. → See article: von Bubnoff, Andreas. 2005. Deadly flu virus can be sent through the mail. Nature (London) 438(7065):134-135.
24. Interviewed on 10/04/2005 by Corie Lok, Nature (London). Topic: career opportunities for young biodefense professionals. → See article: Lok, Corie. 2005. A defensive strategy. Nature (London) 437(7063):1392-1393.
25. Interviewed on 08/08/2005 by Mark Pontin (aka Mark Williams), MIT Technology Review (Cambridge). Topic: the expansion of the US biodefense program. → See article: Williams, Mark. 2006. The Knowledge – Advances in biotechnology have put bioweapons within the reach of terrorists and offer governments new opportunities for violence and repression. MIT Technology Review (Cambridge) (2):44-53 [Online.] http://www.technologyreview.com/BioTech/wtr_16485,306,p1.html [09/07/2009, last accessed.]
26. Interviewed on 07/08/2005 by Barton Reppert (free-lance journalist). Topic: the expansion of the US biodefense program.
27. Interviewed on 01/14/2005 by Ingrid Wickelgren, Science (Washington, DC). Topic: the implications of a WHO decision allowing the genetic manipulation of Variola virus. → See article: Wickelgren, Ingrid. 2005. POX Unlocked? Current Science (Stamford) 90(13):8-9.
28. Interviewed on 11/12/2004 by Dr. David Kestenbaum, PhD, National Public Radio (Washington, DC). Topic: the implications of a WHO decision allowing the genetic manipulation of Variola virus. Broadcasted on 11/12/2004.
29. Interviewed on 08/28/2004 by Dr. med. Astrid Viciano Gofferje, FOCUS (Munich) → See article: Viciano Gofferje, Astrid. 2004. In German: Mit Puppen zum Patienten [From puppets to patients]. FOCUS (Munich) (39):126-128.
30. Interviewed on 08/26/2004 by Dr. Ellen Norten, Bayerischer Rundfunk [Bavarian radio broadcasting], (Munich). Topic: biosecurity.
31. Interviewed on 04/03/2003 by n-TV (Berlin). Topic: biosecurity.
32. Interviewed on 03/19/2003 by Andreas Feiertag, Der Standard (Vienna) → See article: Feiertag, Andreas. 2003. In German: Asphaltfresser und vergrabene Kühlschränke [Asphalt eaters and buried refrigerators]. Der Standard (Vienna) Saturday-Sunday 03/22-23/2003. Topic: the alleged Iraqi bioweapons program.
33. Interviewed on 03/18/2003 by Dr. med. Astrid Viciano Gofferje, Reforma (Mexico City) → See article: Viciano Gofferje, Astrid. 2003. In Spanish: Revelan pasado de istituto ruso [The revealed past of a Russian institute]. Topic: the transformation of the former bioweapons facility State Research Center of Virology and Biotechnology “Vector”.
34. Interviewed on 02/21/2003 by Dr. Harro Albrecht, Die Zeit (Hamburg) → See reprint of the interview. In German: Das gläserne Geheimlabor [The transparent secret laboratory]. Die Zeit (Hamburg) 58(10, Thursday 02/27/2003):34. Topic: the transformation of the former bioweapons facility State Research Center of Virology and Biotechnology “Vector”.
35. Interviewed on 12/17/2002 by Alison Abbott, Nature (London) → See article: Abbott, Alison. Blazing the trail. Nature (London) 423(6941):679. Topic: the transformation of the former bioweapons facility State Research Center of Virology and Biotechnology “Vector”.
36. Interviewed on 12/02/2002 by Dr. Adelheid Müller-Lissner (free-lance journalist) → See article: Müller-Lissner, Adelheid. 2002. In German: Auf breiter Front gegen Biowaffen [An alliance against bioweapons]. Tagesspiegel (Berlin) 12/10/2002. [Online.] http://archiv.tagesspiegel.de/archiv/10.12.2002/341920.asp [10/05/2005, last accessed.]; Müller-Lissner, Adelheid. 2002. In German: Ansteckung mit friedlichen Absichten [Infection with peaceful intentions]. Berliner Ärzte (Berlin) 40(1):21-22. Topic: the transformation of the former bioweapons facility State Research Center of Virology and Biotechnology “Vector”.
37. Interviewed on 08/20/2002 and 08/27/2002 by Ulf Harnack, Laborjournal (Merzhausen) → See reprint of the interview. In German: „Ein Maximum an Transparenz“ [“A maximum of transparency”]. Laborjournal (Merzhausen) (10):26-29. Topic: the transformation of the former bioweapons facility State Research Center of Virology and Biotechnology “Vector”.
38. 38. Interviewed on 03/15/2002 by Dr. med. Astrid Viciano Gofferje, GEO (Hamburg). Topic: the transformation of the former bioweapons facility State Research Center of Virology and Biotechnology “Vector”.
39. Interviewed on 03/14/2002 by Karl Friedrich Gründler (free-lance journalist) for DeutschlandRadio Berlin, Germany; Norddeutscher Rundfunk NDR [Northern German radio broadcasting], Hamburg, Germany; and Westdeutscher Rundfunk WDR [Western German radio broadcasting], Germany. Topic: the transformation of the former bioweapons facility State Research Center of Virology and Biotechnology “Vector”.
40. Interviewed on 03/12/2002 by Eva von Schaper, SZ – Süddeutsche Zeitung (Munich) → See article: von Schaper, Eva. 2002. In German: Ein Paradies voller Viren [A paradise full of viruses]. SZ – Süddeutsche Zeitung (Munich) 58(66, Tuesday, 03/19/2002):V2/15. Summary of the article: K., V. 2002. In Serbo-Croatian (Latin): Rusko-američki rad s virusima. Večernji List (Zagreb) March 26. Topic: the transformation of the former bioweapons facility State Research Center of Virology and Biotechnology “Vector”.
41. Interviewed on 03/12/2002 by Jutta Schmid-Glöckler, Umweltredaktion [Office for the environment], Südwestdeutscher Rundfunk SWR [Southwestern German radio broadcasting], Mainz, Germany. Topic: the transformation of the former bioweapons facility State Research Center of Virology and Biotechnology “Vector”.
42. Interviewed on 12/28/2001 by Steffi Hugendubel, Die Johannes B. Kerner Show, Zweites Deutsches Fernsehen ZDF [Second German television], Mainz, Germany. Topic: the transformation of the former bioweapons facility State Research Center of Virology and Biotechnology “Vector”.
43. Interviewed on 12/06/2001 by Rafaela von Bredow, DER SPIEGEL (Hamburg). Topic: the transformation of the former bioweapons facility State Research Center of Virology and Biotechnology “Vector”.
44. Interviewed on 12/06/2001 by Uli Kulke, DIE WELT → See reprint of the interview. In German: Russlands Biowaffen-Schmiede wird zivilisiert [Russia’s bioweapon facility becomes civilized]. DIE WELT (Berlin) (287, Saturday, 12/08/2001):16. Topic: the transformation of the former bioweapons facility State Research Center of Virology and Biotechnology “Vector”.
45. Interviewed on 11/19/2001 by Dr. med. Astrid Viciano Gofferje, FOCUS (Munich). Topic: the transformation of the former bioweapons facility State Research Center of Virology and Biotechnology “Vector”.
46. Interviewed on 11/07/2001 by Dr. med. Eva A. Richter, Deutsches Ärzteblatt (Cologne) → See article: Richter, Eva A. 2001. In German: Russische Biowaffenlabors: Geänderte Perspektive [Russian bioweapon laboratories: a changed perspective]. Deutsches Ärzteblatt (Cologne) 98(47, Wednesday, 11/23/2001):A3086-A3087. [Online.] http://www.aerzteblatt.de/v4/archiv/artikel.asp?id=29539 [09/07/2009, last accessed.] Topic: the transformation of the former bioweapons facility State Research Center of Virology and Biotechnology “Vector”.
47. Interviewed on 11/07/2001, Hessischer Rundfunk hr [Hesse radio broadcasting], Frankfurt am Main, Hesse, Germany. Topic: the transformation of the former bioweapons facility State Research Center of Virology and Biotechnology “Vector”.
48. Interviewed on 11/07/2001 by Christian Schwägerl, FAZ – Frankfurter Allgemeine Zeitung (Berlin) → See public press article: Schwägerl, Christian. 2001. In German: Mentale Abrüstung – Wie ein deutscher Forscher russischen Biowaffenexperten eine neue Perspektive gibt [Mental disarmament – How a German researcher provides Russian bioweapons experts with a new perspective]. Feuilleton, FAZ – Frankfurter Allgemeine Zeitung (Berlin) (261, Friday, 11/09/2001):58. Topic: the transformation of the former bioweapons facility State Research Center of Virology and Biotechnology “Vector”.

Coverage in Public Press and Scholarly Works:

1. Becker, Markus. 2005. In German: Viren-Versand – Spanische Grippe kommt per Post [Viruses per mail – Spanish flu arrives by mail]. DER SPIEGEL Online (Hamburg). [Online.] http://www.spiegel.de/wissenschaft/mensch/0,1518,384079,00.html [09/07/2009, last accessed; posted on 11/09/2005]
2. Rimmington, Anthony. 2003. From Offence to Defence? Russia's Reform of its Biological Weapons Complex and the Implications for Western Security. The Journal of Slavic Military Studies (London) 16(1):1-43.
3. Dorner, Jens P. 2003. In German: Vom Biowaffenlabor zum transparenten Gesundheitszentrum [From the bioweapons laboratory to the transparent health center]. Mannheimer Morgen (Mannheim) January 16.
4. Stein, Rosemarie. 2002. In German: Dem Bioterror hilflos ausgeliefert? [Defenselessly exposed to biological terror?]. Berliner Ärzte (Berlin) (1):26-27.

Professional Affiliations:

• 06/13/2012-present: Federation of American Scientists (FAS), Washington, DC, USA.
• 2006 – present: Gesellschaft für Virologie e.V. – German Society of Virology (GfV), Ulm, Germany.
• 2005 – present: American Association for the Advancement of Science (AAAS), Washington, DC, USA.
• 2000 – present: American Society of Tropical Medicine and Hygiene (ASTMH), including membership of American Committee on Arthropod-Borne Viruses (ACAV), Deerfield, Illinois, USA.
• 1997 – present: American Society for Virology (ASV), Toledo, Ohio, USA.
• 1997 – present: American Society for Microbiology (ASM), Washington, DC, USA.

Languages:

• English (fluent in speech, reading, and writing).
• French (beginner in speech and writing, proficient in reading).
• German (mother tongue).
• Mandarin (advanced beginner, HSK3 77% on 10/20/2012).

Vaccination Status:

• Anthrax: 07/08/1998, 07/22/1998, 08/05/1998
• Diphtheria: 04/10/1973, 05/17/1973, 07/02/1973, 08/23/1974, 02/01/1997, 11/02/2006, 04/15/2008 (next scheduled 2018)
• Hepatitis A: 08/26/1993, 02/10/1997
• Hepatitis B: 08/01/1996, 09/05/1996, 02/10/1997, 03/13/2003, 04/10/2003
• Influenza A: 2004, 2005, 2006, 02/29/2007, 11/01/2010, 10/11/2011, 09/24/2012, 09/16/2013, 10/21/2014
• Japanese encephalitis: 08/05/1998, 08/12/1998, 08/19/1998
• Measles: 08/23/1974, 10/22/2003, 02/29/2008 (next scheduled 2018)
• Mumps: 08/23/1974, 10/22/2003, 02/29/2008 (next scheduled 2018)
• Pertussis: 04/10/1973, 05/17/1973, 07/02/1973
• Polio: 04/10/1973, 05/17/1973, 07/02/1973, 11/22/1973, 01/24/1974, 11/21/1974, 01/25/1979, 11/30/1984, 01/02/1997, 02/29/2008 (next scheduled 2018)
• Rabies: 02/29/2008, 03/01/2008, 04/15/2008
• Rubella: 08/23/1974, 10/22/2003, 02/29/2008 (next scheduled 2018)
• Rift Valley fever: 06/24/1998, 07/01/1998, 07/22/1998
• Smallpox: 04/26/2001, 04/07/2008
• Tuberculosis (BCG): 11/21/1972
• Tick-borne encephalitis: 03/13/2003, 04/10/2003, 10/18/2004, 12/21/2008
• Tetanus: 04/10/1973, 05/17/1973, 07/02/1973, 08/23/1974, 11/30/1984, 02/01/1997, 11/02/2006, 04/15/2008 (next scheduled 2018)
• Typhus: 02/29/2008
• Venezuelan equine encephalitis: 07/29/1998
• Yellow fever: 07/21/1993, 03/27/2003, 02/03/2014 (next scheduled 2024)

References:

• Sina Bavari, PhD : Chief, Target Discovery and Experimental Microbiology, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, USA
• Prof. Charles H. Calisher, PhD : College of Veterinary Medicine & Biomedical Sciences, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA
• Associate Prof. Michael R. Farzan, PhD : Division of Tumor Virology, New England Primate Research Center, Department of Microbiology and Molecular Genetics, Harvard Medical School, Southborough, Massachusetts, USA
• Prof. Dr. med. emerit. Helmut Hahn : Geschäftsführer der Langenbeck-Virchow-Haus GbR, Vorsitzender der Berliner Medizinischen Gesellschaft [Managing Director of the Langenbeck-Virchow Society, Chairmen of the Berlin Medical Association), Berlin, Germany
• Elisa D. Harris, MPhil : Senior Research Scholar, former Director for Nonproliferation and Export Controls on the US National Security Council staff, Center for International and Security Studies at Maryland, College Park, Maryland, USA
• Peter B. Jahrling, PhD : Director, NIH/NIAID Integrated Research Facility at Fort Detrick, Frederick, Maryland, USA
• Barbara Johnson, PhD, RBP : Former Deputy Chief, Office for Counterproliferation, US Department of Defense, Arlington, VA, USA; and Past-President, American Biological Safety Association, Mundelein, Illinois, USA
• Prof. John Steinbruner, PhD : Professor of Public Policy at the School of Public Policy at the University of Maryland, Baltimore, Maryland, USA, and Director, Center for International and Security Studies at Maryland, College Park, Maryland, USA